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ABSTRACT
This study b3sessed the effects of a 25kDa mycobacterial
component on phagocyte functions associated with antimicrobial
activity. The 25kOa fraction was obtained by purification of
mycobacterial sonicates uSing Sephacryl 8-200 columns. Since the
25kDa fraction could inhibit the intracellular killing ability of
polymorphonuc7ear cells and macrophages, its efferts on various
mechanisms involved in this process were stucl'led. The
mycobacterial fraction inhibited phagosome-lysosome fusion. In
addition, it inhibited the release of lysosyme by the granules
within the phagocytes. The 25kOa fraction also raduc~d the
production of toxic oxygen products, hydrogen peroxide and
superoxide anion (the latter measured by the ability of the
phagocytes to reduce nitroblue tetrazolium) and the activity of
the hexose monophosphate shunt. On the other hand the 25kDa
fraction did not significantly affect the glycolysis pathway used
by phagocytes.
Gtlmma-interf~~ron, but not alpha-inter'ferM. Was able to partially
reverse the inhibition caused by the fraction, indicating a possible
theraoeut 'j c ro1s for this cytoki ne in mycobactar t a1 rii Sease.
Further studies demonstrated an inh'Ibit1on of 1ymphocyte
transformation to mitogens (PHA, Con t and PWM) and to antigen (PPD)
in the presence of macrophagas pretreated with the 25kDa mycobacterial
fraction. Closely related to this is the inhibition of DR expression
by the 25kOa fract1on, suggesting potent escape mecliMisms employed by
mycobacteria to ensure survival within the host.
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CHAPTER 1.
INTRODUCTION &
REVIEW O~ THE LITERATURE
2.
1. PHAGOCYTIC CELLS IN INFECTION
Phagooytic cells constitute an important mechanism of host
defence agai~st ~ny infection (Werb, 1987). The response of
these cells ts non-spectf tc and forms the first line of defence
against t,e invading organism. The phagocyte com,... 'ex falls into
two categories: (;) the mononuclear phagocytes, vhtc' include
tissue macrophages, circulating monocytes and their precursors
tn bone marrow; and (i1) the polymorphonuclear (PMN) phagocytes
(Warb, 1ge1). The mononuclear phagocytes also play an important
role in activating other arms of ths immune system, which
comprise bott1 T and B lymphocytes (Unanue, 1972).
T lymphocytes which mature in the thymus are r$sponsible for the
cell~mediated antigen-specific r'esponse to foreign organisms and
for activating B lymphocytes (Marchalonis, 1980). B lymphocytes
are the antibody producers of the body and are thought to mature
in the bone marrow or foetal liver (stites at a7., 1980).
On exposure to antigen and T helper c011s, B cells develop into
an~ibody producing plasma cells (Marchalonis, 1980).
1.1. HISTORY OF THE MONONUCLEAR
PHAGOCYTE SYSTEM
It was as far back as 1892 that Metchnil<off coined the teno
"macrophage" to icluntify a group of cells which had the abi 1ity
to engulf foreign organisms (Lanaevaart, at el ., 1970). He
recogn 'Ised the close re1at ionsh ip between the phasocyt, i0 ce11s
in the spleen, lymph nodes, bone marrow and connective tissue
and grouped these all tcsethar into the "macrophage system"
3.
(Langevaart et a7., 1970). This concept was then further
developed by Aschoff in 1924 who grouped several kinds of cells
into the reticuloendothelial system (RES) 'langevaart et
a7., 1970). This system included endothelial cells; reticular
cells of the spleen and lymph nodes; histiocytes; splenocytes
and monocytes. This concept was widely criticised stnce
vascular endothelial cells, histiocytes and the reticular CElls
of the lymph nodes and spl~en differ vastly from one another
(Langevaart et et «, 1970). At a conference on mononuclear
phagocytes in Leiden, in September- 1969, it was therefore
decided to re-define the system as the mononuclear phaSocyte
system (Langevaart at a7., 1970).
1.2.
1.2.1.
PHAGOCYTE ONTOGENY
Mononuclear Phagocyte Ontogeny
The mononuclear phagocyte originates in th~ bone marrow as a
common progenitor of the granulocyte, erythroid megakaryocytic
and macrophage lineages [Colony forming unit CFU - GEMH (Welte
et st., 1985) or pluripotent stem cell (S1eff, 1987)J. A
gtOUp of glycoprotein hormones. termed colony stimuiating
factors (CSF), will then induce the differentiation of this into
the various cell lineages (Slaff, 1987). Pluripotent CSF is the
colony stimulating factor which 1'1111induce the CFU-GEMM to
differentiate into progenitors for each of the separate cell
lineages (Welte et ~7., ~985). It has been postulated that
GM-CSF (granulocyte macrophage CSF) governs the rata and
percentage of monocytes and granulocytes that emerge from the
bone marrow (Sawyer et 87., 1989). Differentiation of the
4.
CFU-GM (granulocyte monocyte CFU) into tbe two different
lineages appears to be modulated by the availability of colony
stimulating factors. Studies with recombin~ht GM-CSF indicate
that high concentrations favour formation of granulocyte
colonies wherea~ the use of low doses resulted in the
predominant formation of macrophages (Metcalf, 1980).
The CFU-monocyte (M-CFU) which result~ from differentiation of
the CFU-GM in the presence of macrophage-CSF (M-CSF or CSF-1
(S1eff, 1987) will differentiate into a monoblast Which in turn
differentiates into a promonocyte, the first ~Iorpho'ogically
identifiable cell in the mononuclear phagooyte series (Johnston,
1988). The transit time in the bone marrow frt,'IlCFU-GM to a
mature monocyte is about 6 days (Groopman & Golde, 1981). Newly
formed monocytes may remain in the marrow for approximately one
day and then Mter the blood stream where their half life is
thought to be approximately 3 days (Van Fu:'th at al«,
1979). Circulating monocytes constitute a mobile pool of
incompletely differentiated calls on their way from their site
of orig1n to the tiSSIJes. These ce11s are heterogenous with
respect to their cell density, size, morphology and surface
antigens (Van Furth et a7., 1979). No evidence is available
however to suggest that monocytes are destined for any
particular tissue and migration to various tissues appears to be
a random phenomenon in the absence of inflammation (Johnston,
1988). It has beertsuggested that once in the tissues,
monooytes do not re-enter the oirculation but undergo
transformation inta tissue macrophages. These macrophages
5.
would now demonstrate morphological and functional properties
characteristic for the tissue in which they reside (Van Furth
et 87., 1979) (Figura 1.). The terminal stage of
development in the mononuclear-phagocyte line is a
multinucleated giant cell (MGC) which characterises
granulomatous inflammatory disease, such as tuberculosis
(Johnston, 1988). Both monocytes and macrophages appear in the
lesions in these diseases before the appearance of giant cells
and they are therefore thought to be the precusors to these
multinucleated cells nlariano & Spector, 1974). Monocytes kept
in cultUre for 3-10 days develop general features of tissue
macrophages and some of them fusa into large MGC's (Schlesinger
et a7., 1984). The MGC's are as efficient as macrophages
in:
(a) ingesting sheep erythrocytes coated with IgG and Candida
a7bicans,
(b) degrading ingested yeast,
(c) reducing n1trob'lue tetrazo11um, and
Cd) expressing Ia antigens (Schlesinger et a7., 1ge4).
Although the act1v1ty of ~-glucosamin1dase, acid phosphatase and
s-sruccrontdeee per call is greater in MGC's, the spec tf tc
activity of the enzymes is greater in macrophages, These
studies indicate that MGC's have the capacity to fl Ic:tiot\ 'like
macrophages in host defence against infection (Schlesinger et
si., 1984).
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Polymorphonuulear Phagocyte
Ontogeny
Tho PHN or granulocyte originates from the CFU-GM. The CFU-GM
1.2.2.
initially d1fferent1ates in the presence of a-CSF (granulocyte
CSF) to form a OFU-G. The CFU-G will further differontiate into
a myeloblast. The myeloblast then divides and differantiat~s
into a myelocyte. Subsequently, during a 7 day postm1totic
period, cytopla,c;micand Mclear changes occur that result in a
fully mature and functional PMNcell (se ;yor at el •• 1989).
Tho PMN ce'll acquires 2 major populC1tions of gr£\nules:,
(i) the primary or azurophilic granules which contain
myeloperoxidase, acid hlf-lrolas(ls, 1ysosyme , cationic
proteins and neutral protease; and
(11) secondary or sr,ecifie sranutes wh';ch contain 1actofarrin,
1y:sosyme , vitamin Bu-binding pr'otein, cytochrOl'll(:)b,
collagenase and certain receptor molecules (Sawyer et
a7., 1989). Circulating PMN cells represent only 5~ of
the t~ta' body pool of granulocytes (Snwyer et a7.,
1989). About half of the intravascular population of PHN
calls are not circulating but are adherent to the
endothelium of $fI)allvesse'ls (margination of PMt~ cells)
(Warb, 1987). PMN cells eotor the tissues, where they
remain functional for 1-2 days, after which the senescent
PHNcells are fGiilO'led by splenic IIlllcrophages or are
discharged from mucosal surf~ces (Sawyer Bt a~.,
1989).
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"'-------------,.. TISSUES(functlon 1...2 days)
FIGURE 2. polymorphonuclear nhagooyte ontogeny (Adapbed from Cline, 1975)
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The Colony Stimulating factors
( CSF)
With the development of techniques for the c10nal culture of
1.2.3.
haamatopoiet1c ce11s in semi-so1id culturo mediumt it became
possible to analyse the events occuring during haematopoiesis
(Metcalf, 1985). It was found that progenitor ce1ls are
intrinsically incapable of unstimulated cell division. A
continuous stimulation by appropriate specific regulatory
molecules is required for such division (Figura 3.). These
moleCUles or hormones are cOllectively known as colony
stimulating factors (CSF's) (Metcalf, 1986). Five C$F's hdve
been identified:
(i) multi~CSF (or XL-3),
(11) OM-CSF,
(i 1i) G-CSF,
(iv) M-CSF (or CSF-i), and
(v) eryt.hropoiet'l n (ep).
These fact(lrs are produced by many calls in the body including T
lymphocytes, monocyt~s, endothelia' C~"Sand fibroblasts
(Si~ff, 1987). Whon monocytes are activated with endotoxin they
produce G-CSF (R',nn1ck et st., 1987), and the monol<ines
tumour necrosis factor (TNF') (13eutle,·,1990) and interleukin 1
(XL..n (ntnaret lc, 1984). These monokines may, in turn, induce
T lymphocytes to produce both GM-CSF (Her~)ann at 67., 1988)
anq multi-CSP (Kelso at al., 1086) and may also induce fixed
bone marrow stromal ce11s to produce ~M-CSF and Q-CSF (81off,
'986: Zucali et a7., 1986). In addit10nt macrophagss are
capable of contro111ng the concentrat'lon of thp"r own growth
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factor (aartocct (it «t., 1981). M-CSF (CSF-1) is produced
inmost tissues at ,11 constant rate and is removed by receptor-
~adiatod endocytosis by the macrophagas of the sp1een and liver
(h",meat 8 7., 1987). Mature lIlacrophageshave been shown to
be more affective than proliferating progenitor cells in
1nternalising and degrading M-CSF (B&rtocci at 07., 1987).
It is thereforE! felt that M-CSF may participate in a feedback
,. hereby macrophagas control the produotion of monocytes by
'19 marrow (Hume at a 7., 1988).
l :3. ANT!GEN PROCESSING
On~e phagocytes recognise a foreign antigen, several processes
are initiated. These include binctini9 of antigen to the sufaca:
internali~:ll'i"nof microbes; active metabolic processing Md
catabo 11sm of mac rome 1ecu 1as. In the case C) f mac rophages ,
8tltigM is tGcycled to the surf'ace and presented to T
1ymphocytas in association with Cla3s II major
hist~computibi'ity antigens (Werb, 1987).
Antigen Binding to the Cell
Sll rf<;\ce
Antigens adhere to the macrophage cel' surface either via
specific Fc and 03 receptors or via non-covalent interactions,
such as the zymosan receptor system (RicheE) at a7., 1988),
The latter may represent a more primitive recognition system
that recognises yeast and other microbial organisms before a
11 •
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FIGURE 3. The colony stimulating factors andtheir effect on phagocyte ontogeny.
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specific immune response is mounted by the host. The former
system indicates an evolutionary advanced stage whereby
immunoglobulin and complement enhance the ability of the
macrophage to ingest organisms (Riches et 87., 1988).
1.3.1.1. Zymosan Receptor System
Zymosan particles are a carbohydrate ricin cell wall
preparat ton derived from the yeast Saccharomyces cerevtetee
wlrlch are recognised and avidly ingested by monocytes and
macrophegas (Ezekowitz at £17'1 1985), This property has
rasult~d in the extensive USe of zymosan particles for the study
of macrophage responses, Three receptors playa role in its
binding: a D-mannan/ fucose receptor (MFR), a (3-0 glucan
receptor and a macrophage-membrane receptor for the third
component of complement (CR3) (Riches at 87., 1988). The
rs 1at ive tmpcrtance of these 3 receptors has as yet not been
established, but the ~-glucan receptor appears to be a common
factor among Uh1 various monocyte and macrophage populations
tha{~ respond to zymcsan. The MFR however) has bean suggested to
be expressed on 1y on mac rophaqas (shephe rd et a7. I 1982).
Since human monccvtes do not express functional M!='R, other
recognition mechanisms for zymosan rr~ustbe operative in these
cells. To thi~ end, Czop & Auste~ (1985) demonstrated that
tncubat ton of human monocytes with inso1uble ~"91ucan led to a
striking inhibition of zymosan phagocytosis. Such findings
indicate that [3-alucan receptor is important for phagocytosis.
, ..,
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opsonisation of zymosan particles may also be mediated by
products of complement activation as evidenced by the studies of
Ezek()witz et 87, (1983) who found 03 cleavage products
deposited onto the zymosan partic1es, thus allowing the
opsonised zymosan particles to be internalised via the 03
receptor on monocytes and macrophages.
1.3.1.2. The Fe Rec e.p t o rs
Unlike the situation witb the binding of zymosan particles,
the receptors involved in the binding of 19G~containing antigen/
anttbodv complexes have been more cleer ly identified. There are
3 ISG Fc receptors:
(i) FcR! which is a high affinity reCG tor expressed on
monocytes and tisslle macrophages (Anderson, 1982) but not
on PMN ce11s unless stimulated with IFN-gamma (Shan,
1988),15 relatively specific for monomeric and aggrl~gated
laG 2a (Heusser at 87., 1917; Unkeless, 1911);
(.:n FeRI! 'Is a low affinity receptor for ISG which in
specific for aggregated and antigen-complexed rgG 1 and
19G 2b (Diamond & Scharff, 1980). This receptor is the
only Fe receptor found on unstimulated neutrophils and is
found on monocytes and tissue macrophag9s (Ross et
87.,1989);
(iii) FcRII! is also a low affinity receptor which binds
~ggregated IgG 3 (Diamond & Scharff, 1980) and is present
in high concentrations on neutrophils but is absent in
resting monocytes. Tissue macrophages and macrophages in
culture express variable amounts of this receptor (Ross
et ei., 1989),
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The Fc receptor most thoroughly investigated is the IgG
1/2b re<;9ptor to which two functions have been ascribed,
namely that of a Na+/K+ ion channel (Young at 87., 1985)
and that of a phosphalipase A2 (Suzuki at a7., 1982).
Both these functions then play an important role in the
elicitation of various macrophage and neutrophil functions
involved in host defence and inflammation, tncludtns the
secretion of lysosomal enzymes, the productton of reactive
oxygen metabolites and arachadonic acid metabolism (Riches
at l.1 7. I 1988).
1.3.2. Ingestion of Antigen
once foreign particles bind to their respective receptors,
the cell membrane invaginates to form a phagocytic vassf cle or
endosome (Werb, 1987). It has been demonstrated that this is
an GnElrgy requiring process and is inhibited by sodiut1lazide
and 2-deoxyglucose (Sharma, 1986). These agents have been
ehown to inhibit the oxidative and 91ycolytic metabolic
pathways (Sharma, 1986). Once formed at the periphery of the
cell, the endosome flows into the cytoplasm of the macrophage
towards tho perinlJcle~r area, gUIded by microtubulas in an
energy requiriiig process that utilises the abundant amount of
cytopldsmic contractile prote1ns (Werb, 1987).
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1.3.3. Antigen Degradation
In the perinuclear area the phagosome fuses with lysosomes to
form a phagolysosome or secondary lysosome (Werb, 1987). At some
stage between the init'lal formation of the phagocytic vsss icle
membrane and the formation Qf the secondary lysosomal membrane,
the contents become acidified and portions of the membrane,
plasma membrane receptors and some of the contents are recycled
back to the cell surface (Werb, 1987). The phagocytosed
cont~nts are then digested by hydrolytic enzymes within the
1ysosome (Sharma, 1986).
1.3.3.1. Lysosomal Enzyme Release
1.3.3.1.1. Stimulation of Enzyme Release
The secretory proCeSS of lysosomal enzymes by macrophages has
been shown to be alower than that of neutropht ls, beginning
within 5 minutes af'tar the addition of a phagocytic stimulus
(Welschar & Cruchaud, 1976) and continuing for 6-12 hours (or
longer) before reaching completion (Riches & Stanworth, 1980;
Schorlemmer at 87.,1977). IL has been shown that early
lysosomal enzyme release is independent of new protein synthesis
as evidenced by studies indicating the ineffectuality of
cycloheximide on lysosyme release (McCarthy et 87., 1982).
It is therefore postulated that early enzyme secretion occurs
from preformed intracellular stores (McCarthy et ti7.,
1982). SUC'ltainedrelease of lysosomal enzymes over a prolonged
period however, is dependent en protein s~lIth(lsis(Schnyder &
~aggiol;ni, 1978).
.'
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The biochemical requirements of the induction of lysosomal
enzyme secretion have not been clearly defined (Riches et
a7., 1988). It is possible that phospholipid breakdown is a
requirement in the initiation of enzyme release since an
increased turnover of phosphatidylcholine during eXposure of
macrophages tr ·ymosan parti~les has been noted (Channon et
17., 1987). Furtl.rmorR, dapsone, an inhibitor of
phosphatidylcholine turnover has also been demonstrated to
inhibit enzyme release (Bonney at 87., 1983). However the
role played by phospholipid turnover (if any) must still be
fully determined since protein kinase C (PKC) and calcium levels
appear not to be implicated in inducing enzyme release (Riches
at a7., 1983; 1988).
Lysosomotropic weak bases, such as ammonium chloride,
methylamine or chloroquine, have also been shown to induce the
release of lysosomal enzymes (Riches & stanworth, 1980).
Although their' mode of action is not known, it has been
suggested t.hat alkalinisation of the cytoplasm and/or the
lysosome is necessary for lysosomal enzyme r~lAase to occur,
Segal et 87 (1981) showed that following phagocytosisj there
is an elevation of the intravacuolar pH via the electron
tran~port chain which transports electrons from the cytosol to
the lumenal surface of the vacuole. The resultant reduction of
molecular oxygen to 02- consumes protons ':luringthe formation
of H202 (Root at 17'j 1975), thereby raiSing the
intrucellular pH (Segal, 1981). This raised pH facilitates
killing and bacteriolysis by granule proteins which are i~active
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at l~w pH values (Segal 1989a). Following this partial
degradation by these proteins, the pH of the vacuoles is rapidly
reduced to optimise the activities of hydrolases and other
proteins that require an acid pH for optimal activity (Hirsch,
1956).
1.3.3.1.2. Lysosomal Enzymes & Proteins Involved
in Bacterial Killing and Degradation
It is well documented that a variety of enzymes are released
by macrophages and neutrnphils (Werb, 1987; Papadimitriou &
Ashman, 1989; Johnston, 1988; Unanue, 1976). A list of these
enzymes is presented in Table 1. Enzymes derived from
phagocytes have been shown to digest bacterial macromo lenules
such as complex carbohydrates, prote~ns and lipids to su)-uni-l;.s
of molecular weight of 200kDa or Iess (Warb, 1987). These
enzymes include:
(i) ~.y'~Q§YJn§: This enzyme has been shown to have a limited
~pectrum of antibacterial activity, due partly to its
ability to cleave a a 1-4 linkage between the
N-acetylglucosamil1e and N-acetylmuramic acid residues
(Unanue, 1976). With regards to its production, lysosyme
has been shown to be synthesised within phagocytes
(McClelland, 1975). Release of the enzyme into the
extracellular m~ lieu appears to be rapid and this rate
may be increased many fold in response to phagocyte
activ~tion, for example by in vitro culture of
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macrophages or in alveolar macrophages expo~ed to
inhaled particles (Heise & Myrvik, 1967). The release
of lysosyme however appears to be independent of
phagocytosis as evidenced by studies demonstrating that
a phagocytic stimulus does not alter the amount of
lysosyrne secreted (Unanve, 1976).
(i1) Neutral Proteinases: Collagenase pnd elastase, in
contrast to lysosyme, are secreted in sm.:-'lamounts by
unst tmul ated phagocytes (Uneue , 1976). Fo11oW'lng
stimulation of these cells by phasocytos is or endotoxin,
the production and release of these enzymes is
considerably increased (Werb & Gordon, 1975a;b).
Together with 981 atinase these enzymes are important in
the degradat ion of connect iva tissue maeromo 1ecu res such
as elastin, collagen and proteoglycans (Sharma, 1986),
They may also promote the r:,; grat ion of macrooneses
th', ,gh basement membranes (Werb, 19B7). Elascase~ in
al';:lition,has the capacity to d~grade immunoglobulins,
alpha-proteinase inhibitor. fibronactin and fibrinogen
(Werb, 1987).
(iii) ~Y.$Q~g_Il)~1AQ.1.cLH.Y.Qr_g_la§,El_§:The hydro 1ases secreted by
phasocytes inc"ude f3 91ucorant dase , n-acetyr-p
glucosaminidasB, alpha mannosidase and acid
phosphatase. Non-el icited macrophages secrste very lOvl
levels of these acid hydro lusea. Once activated by cell
culture (ScMyjer & Baggiolini, 1978) or inflammatory
stimuli, such i:t~ thioglycollate (Schnyder & Baggiolinl,
1978), type-sp~cific polysaccharide and peptidoglycan
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TABLE 1. Enzymes Secreted by Phagocytes.
-.~------"-.-~-"-----------------......,
Ac id :Wd ro 1asas
Phosphatase
Glycosidase
R;Qonuclease
Dpoxyribonuclease
Proteases
Lipase:::
Sulphatase
Other, Cathepsin D
N~utral proteinases
Collagenase
ela.stase
MYEl 1;nase
Proteoglycan protease
Cytolytic proteinase
Plasminogen activator
Lysosyme
Arg; Y1aSe
Lipoprotein 1ipase
An9iotansin convertase
Protein kinase
BPI lbactericidal/permeability increasing) protein
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(PPG) from group A Steptococci (Davies et a1.,
1974), products from act.ivated lymphocytes (Pantalone 8<
Page, 1915) or by primary amines (Riches & Stanworth,
1982), the amount of hydrolases released is markedly
increased. The secret10n of the hydrolases can b~
dtvtdsd into two categories. In the first, a variety of
stimuli will induce the rapid secretion of the enzymes
within 1-4 hours (Musson et a1., 1980). This rapid
release is similar to the release of these enzymes by
nautropht la (Henson, 1980). In the second, a more
prolonged secretion of the acid hydrnlases in raaponae to
lower concentrations of stimul'j occurs. This can be
maintained for up to 2 weeks in cultura and is dependent
on protein synthesis since cycloheximide will inhib'lt
their re1ease (Schnyder & 13a991011n1, 1978).
(1v) Gf.ltiPt1iQ,Pro.tejl1§:A group of chymotrypsin'"like cationic
proteins that ~xh1bit microbicidal properties wera
id\.t)tified 'In human granu10cytes by Odeberg & 01sson
(1976) who also showed that the microbicidal effects of
these proteins did not depend an the proteolytic
activity, BPI is another cationic protein with
anti-microbicidal properties identified in P~lN col is
(Elsbach at a7., 1979) and was named BPI for its
bacter'lcidall permeability increasing properties. A
third sro'Jp of cat tonto peptides wore 'identifiod in
rabbit PMN calls (Selsted at 87., 1985) and latar in
human granulocytes (aana, 1986). Six of these tJrotoins
iso1ated from rabbit PMN cans have boon aaquenced and
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are cysteine and arginine rich peptides of 32-34 amino
acids (Salsted at al., 1985) and are members of a
family of proteins known as de.f~n~.in.~(Ganz et: 8].,
1985). These molecules kill organisms as diverse as
Staphy1ococcus aureu$, Pseudomonas aeruginosa,
Escherisch1a co 7 t, crvptooooaus neotomen« and even the
enveloped virus Herpes simplex (aanz at a1.,
1985). Three similar low molecular weight pept1des have
been isolated from human granu10cytes and are called
human neutrophil peptide (HNP) 1-3 (Ganz at a1.,
1986) and play an important role in the microbicidal
~3chanisms employed by the granulocytos. Th~se molecules
havo, as yet, not been identified in human macrophages
(Rook, 1989). The bactericidal aot'!vity of cationic
proteins is generally at a pH of between 7.0 and S.O.
The pH of the phagosome transiently rises to this level
end the proteins can then displace the qivalent cations
(e.g. Ce2+), which cro$s~11nk the end~toxin molecules
in the outer r.iembraM of Gram negative crsantses (Sawyer
at aT., 198J). The pH in the phagosome subsequently
drops (S~gal at sr., 1981). tn this mora acidic
envt rcnnsnt the major effect seems to be the
pormeab·11s&tion of the outer membrane which may then
a110w entry of other microbicidal molacu1es into the
organism (Rook. 1989), In addition to the releCSG of
these lysosomal substances, the macrophage enhances its
bactericidal capacity by taking up products of
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neutrophils such as the defansins and lactoferrin
(Prllzanski et aT., 1984). The latter is effectiVe in
e1th~lr kill ing bacteria di rectly or by interacting with
reactive oxygen radicals to facilitate the generation of
hydroxyl radicals (Ganz et 07., 1985). The partially
catavol1sed protoih resultiil~ from these degradecive
mechanisms can then be re1~ased from the ceil into thE!
extr-acellular ~i1':€'u6t!1 be taken up by other macrcchases
for reprocessing ur can remain on the cell surface to be
praseured tel other ce11s of the immune system (unanus &
Al1on, 1986).
1.3.~.2. ~xidative Intracellular Killing
Mech<ll,isms
1.3.3.2.1. Activation of the Reactive Oxygen
Motabolite producing system
The term 'resp1 "dtory burst' refers to a co~ordinated series
of oxygen dependent metabolic events that take place when
phagocytes are exposed to appropriate stimuli (Segal, 1989a).
It was originally thought that the sole purpose of this rise in
oxygen consumption was to provide energy for phagocytosis
(Babior, 1978a), but Sbarra & Karnovsky (1959) showed that
phagocytosis occured under conditions Qf either high nitro~en or
high oxygen concentrat.ions. These findings left unexplained tho
reason for the tncraasa in oxvsen t.lptake following act ivat ton of
phugocytes. However. lyer et a1. (1961) demonstrated that
at least part of the oxygen consumed in the respiratory burst
wa~ converted to nYdrooen peroxide (H202) and they proposed
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that this H202 was used as a bactericidal agent. The
initial response to an activating signal by the respiratory
burst is activation of a NAOPH oxidase complex which catalyses
the production of superoxide anion (02-) (Pick at a7.,
1989). NADPH oxidase is therefore of central importance to the
production of reactive oxygen metabolites (Babior, 1984).
Activation of the 02 dependent pathway is induced by opson;sed
bacteria and zymosan, phorbol myristate acetate (PMA)j
complement component C5a and fluoride ion (F-) (Baboir, 1978a).
This multicomponent oxidase system forms an electron transport
ohain in the Plasma membrane (Riches et al., 1988).
The components of the electron transport chain that have been
identifiea are a proteir. of molecular weight between 65 and
671<0a (which may be a flavoprotein) (Segal, 1989b), a 47kDa
cytoso1ic protein (Clarke at a7., 1990) and cytochrome b
(Riches at aT., 1988). The cytochrome b found ill
macrophages, monocytes and neutrophils occurs in the plasma
m~mbr'ana and becomes ;ncorporated into the wa 11 of the
phagocytic vacuole (Segal, 1989b). The cytOchrome b consists of
:::subunits - a 221<1.. \ protein and a 91kDa g1ycoprote1n (Clark
€It 07., 1990). The 65-67kDa protein is cytosolic (Ricbes
at a7" 1988; Clark €It a7'1 1990) and is thermf.~~
tr-anslocated from the cell intorior to the plas; _.m",OiI:)ranewher\':!
it binds to NAPPH and probably acts as 1;\ proximll component of
the entire electron transfer system (Segal, 1989b),
24.
Superoxide generation ;s generally studied by activation with
PMA (Riches at 87., 1988). PMA activates protein kinase C
(PKC) and causes its translocation to the plasma membrane
(Sha'afi, 1988). The ( tivated PKC will, in turn, activate the
NADPH oxidase systam by phosphorylating one or more proteins
(Clark et 87., 1990). One of the proteins phosphorylated is
a 47kDa cytosolic protein which then associates with cytochrome
b in the membrane (Segal 1~ ib). By this series of reactions an
electron is transfered ultimately to molecular 02 to form
superoxide (02-) and NADP+ (Sogal 1989a). Figure 4 is a
schematic representation of the NAOPH oXidase system. The 02-
produced by this series of reactions then dismutates to form
hydrogen peroxide (H20~) (Figure 5) (Segal, 1989a). Thi,
dismutation occurs spontaneously at a Very slow rate (Becknr ,
1988). The presence of superoxide dtsmutass found in the
cytcp lasm of many cells, however, greatly increases this rate
thereby protecting the cell against the ravages of 02-
(Fridovich, 1986).
Glutathione is a constituent of most, if not all, cells and its
function i3 thought to'be the neutralisation of H202
produced in the cells in order to protect the ce'l l from
sa 1f-destruct ion (Me1tzer , '1977). In the presence of
glutathione peroxide and H202, glutathione wi1l be oXidised
with the raleasa of H20 (Figure 6). The oxidisad glutathione
(G-S-S~G) is then reconverted to its r~duced state (GSH) by a
glutathione reductase reaction (Figure 6) (Reed! 1989) which
yie1ds the oxidised NADP+. The NAD?+ Wh1Ch accunlulates as u
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CYTOPLASM PLASMAMEMBRANE EXTRACELLULAROR
INTRAV ACUOLAR
PMA
FIGURE" 4. Human PMN NAOPH oxidase.
(Addpted from Clark. 1990).
FIGURE ~.
26.
Superoxide
Dismutase
Productio~ of hydrogen peroxide.
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result of these two pathways will then fuel the hexose
monophosphate shunt (HMPS) by which glucose-6-phosphate will be
oxidised to form 6-phosphogluconate in the presence of the
enzyme glucosO-6-phosphate dehydrogenase (Figure 6 Reaction 3 -
redrawn from Metzler, 1977).
Glucose oxidation through the HMPS is increased during the
respiratory burst due to the increased production of NADP+ which
is the rate limiting step of the process. ~ach molecule of
glucose which is phosphorylated and subsequentlY metabo1ised by
the HMPS reduces 2 molecules of NADP to NADPH thus replenishing
the supply of reducing 81aents necessary for the operation of the
respiratory burst (Figur'1! 7) (sab tor , 1984).
1.3.3.2.2. Bactericidal Mechanisms of the
Reactive Oxygen Metabolj~e$
A. §M~eroxide radical: There is controversy about the
microbicidal potential of this anion since Gregory at
a7. (1973), Gregory & Fridovich (1974) and Mandel' (1975)
could not show microbicidal activity by artificially
generated 02-. However, it is possible that the
concentration of 02~ production in such systems may be
much smaller than that produced in the vicinity of the
phagosome (Babior et a7'1 19(5),
G· 6· P
6 • Phosphogluconate
NADP+
NADPH
2 GSH <, HO2 2
N
0:>.
Figure 6: Glutathione - dependent system.
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Figure 7: The Hexose Monophosphate Shunt. (Metzler 1977)
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B. HygrQwJ_r~iGCll (OH-): The hydroxyl radical is a b19hly
unstable oxidi~ing species that reacts almost
instantaneously with most organic molecules that it
encounters (Babior, 1978a). Evidence that both macrophages
and neutrophils produce OH- has been obtained by Wais~ et
a7. (1977) and Tauber & Bab10r (1977). The mechanism by
which the cells produce OH- is un~ertain but nne
possibility is that OC1-, a product of the myeloperoxidase
reaction (discussed below) reacts ,;'!th k ~2 (Figure 8 -
reaction 1) to produce singl~
the Hab~~ Weiss reaction, forms G
(Klebanoff & Rosen, 1978).
-, 'tu;"n 1'1.:1
~,.,tion 2)
C. !iY.drogenpero)lide and myelQQerClxidasel:Although H2U2
has a certain amount of bactericidal potency, its potency
is greatly augmented through the act ton of the enzyme
rllyeloperoxidase(Babior, 1918a). Th'ls enzyme ts present in
azuropht ltc granules of neutrophils t:lr.•4 monocytes (Bainton
& Farquhar, 1968; Lehrer Be Cline, 1969; Salmon at a7.,
1970) and catalyses the oxidation of ha1ide ions to
hypohalite ions by H202 (Fi~ure 8 - reaction 3),
01-, Br- anw I- can be oxidised by this enzyme (Klebanoff,
1968; Klebanoff & Shepard, 1984). Several mechanisms ha'le
been proposed to explain bacter ta] killing by the
Hz02-halide-myeloperox1dase system. The first is the
possible halogenation of t~o lacterial cell wall, which
will cause a loss of integrity of the wall leading to cell
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death (Zgliozynski & Stelmaszynska, 1976). The second
mechanism is the generation of oxidants belonging to a
gene ,"a 1 family of nitrogen-chlorine derivates Ilhich are
::er,eroted Ilia the myeloperoxidase··mediated chlorination of a
nitrogenous vompound (PigurA $ - react ton 4) (R~NH) (WaiSiil
et a7., 1983). Compounds available to react with HOCl
are e.mmonia (produced dUr'ing neutrophil metabolism) (Grisham
at a7., 1984), taurine (most abundant free amino acid in
1eukocytes) (Test et a7., 1984); amines; nucleic acids;
po1yamiMs and cationic p~ote1ns (Test et a7., 1984).
The NmCl derivatives produced and r~leMed axtracellularly
Bf'O long lived, hydrophilic, low molecular weight cOMpounds
w'ith low tOXicity but which can react with aMMonia to yiold
o lipophilic oxidising agent monochloroam1ne (Grisham et
a7., 1984). Tho addition of ammo~ia therofore confers the
RNHOl derivativos with bactericidal, cytotoxic and cytolytic
pI'opel'ties (Grisham at 8.7" 1984). The third Mochanism
by which the myeloporoxidasEl systom may be bactoricidal is
py ganoro,t1ng singlet oxygon 102 (Figure 8 - react ten 1)
(Roson 8. Klebanoff, 1977). Singlet oxygM diffors from
utmosphlwic oxygen in the distribut.ion of the eloot.rons
areune tho two nuclei. In atntoophoric oxygon the electrons
form a cylindl"ical cloud in which tho axis 10 tho lino
joining tho nuclei. In singlet oxygon this aloctron cloud
is distorted away from a ()y1indricu1 configuration, thoroby
altar1ng ~ho chemical nropert1es of the molecule.
Reaction 1
Reaction 2
Reaction 3
W
I\l.
_ myeloperoxidaseH 0 + Cl " ~. . ~ HOCl + H 0
a 2 I 2
/"RNH
RRNel + H2O!
Figure 8: Production of reactive oxygen metabolites
React:ion 4
This highly reactive singlet '02 has the ability to
attack a large variety of double bond containing compounds
thereby inflicting lethal damage on tho biological systems
it comas into contact with (Bab1or, 1918a),
1.3.3.3. Role of Reactive Oxygen Metabolites
Although the exact mechanisms by which tha products of the
respiratory burst are invctved in bocteric1dal ac:t1vtty is far
from clear, their importance cannot be doubted (Segal, 1989b).
Abnormalitias of the enzymes Involved in the various reactions
of the rospiratory burst have been demonstratGd to resu1t 1n
sevare recurrent infections (Holmes at 81" 1967). An
oxt.f11ple of SUch abtlorf11alitie~ is apparent in chronic
srnnutcaatcus disease where thare 1$ an absence of one of the
compQ~ents of the NADPH oxidase sY$tem responsible for the
productio1 of 02- (Bab1or, 1918b).
1.4. ANTIBEN PRESENTATION BY MACROPHAGES
An important role of tho macrophage is the activation of the
antigenw~pecific arm of the immune response. Fishman & Adler
(1963) showed that under certatn conditions antibody responses
do not occur' upon exposure to antigen alone but ra.ther upon
interaction with macrophages which had pre~lously phagocytosed
the nnt.i(lon. II/arkdone at the National Institutes of Health,
Bethosda, Mat'ylnnd has shown that the initial ant+sen binding
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ce l l in a lymphoid cell enr-iched population 1,) an adherent,
phagocytic, radio-resistant can that appears morphological1y to
be a macrophage (Rosenstre1ch & Rosenthal, 1973; 1974; Waldron
et 87., 1913). Their studies also indicated that antigen
recognition involved an initia'! obligatory macrophCl90 uptuka of
antigen before interaction of the immunogenic moiety with the T
lymphocyte took place. Close contact between the antigon-
bearing macrophage and lymphocyte was also shown to be essential
since separation of the macrophage bearing antigen and the
lymphocyte by a 0.45 micron filter did not al low for initiation
of lymphocyte pro11feration (Cline & Swett, 1968).
\Jpon binding to the macrophage, the bulk of the antigen is
degraded, but for successful presentation of antigen to i cells
to take p1uGS only partial catabo1isM may occur (Unanue &
Oalderon, 1976). Unanue & Calderon (1975) have'shown that
antigen may bypass extensive catabo1ism by 2 mechanisms, either-
by remaining on the surface membrane for a cr+ttcal period of
t.mo, or by baing released frC/m the cell prior to oxtensive
breakdown. Using albumin as an antigen, Schmidke & Unanue
(1f,Jli) show(ld 1:hat there is hetaroseneity in the rate of
cnt abo 1i(Jill of trio anti sen, with degradation of pl'ote ins havi n9 a
half life varying fl'On1 0.5-22 hours. ,\lso 10~26% of the a11:1um111
bound roststs catabol ism and is stored in a stab le f·,rm with
approximately 0119 thi rd of it beins on the cell surface
(Rosontha1 et at., 197f,). E11ner & Rosenthal (1976) showed
that during the catabo1ism of 2.4 d1n1trophany1 guinea pig
albumin (I)NP~GPA)80%of the initially col1 bound materia' was
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released from the macrophagB, whilq 20% of th~ ptable residual
material remeined surface associated This surface associated
res idUB 1 anti gen \IIOU 1d then be presented to the T ce 11.
Ziegler & UnanuB (1981) also showed that the macrophage had to
be viable, at least for a lag period (the durat10n depending on
the amount of antigen and temperature), presumab1y during which
time antigen processing took place; 1f the cans were then fixed
with parafot'ma 1d€lhyde, antigen presentat ion to T cells \'las
unaffected. Sh1rnonkewi.z et: el . (1ge3) further
substantiatod this by nhow1ng that macrophagas fixed in low
concentrations (0.05% final concentration) of glutaraldehyde
WGre not able to present native or denatured OVA but were abie
to present proteolytic fragments of the molecu1e. One other
aspect ~ successful antigen presentation is the genetic control
of the ant ire process. For act ivat ion of the T 1ymphocyte by
mocrophClges r ing ant~Hon to occur the 2 coll popu1ations have
to be synGsnsl_ (Shevach & Rosenthal, 1973; Rosenwasser I
[ios~)nthal1 19'19); if T (:0118 ft'(iffi 1 strain of gu' p1g were
mtxsd with muct'Ophages of another atratn, antigon independent
birJdill9 would occur', but antigen dependent binding and
subsequent activation of the T calls would not (LipSky &
Rosenthal , 1975), In i.lddition, the in vitro responses of
primed guinea pig T calls to antigens, the response of which is
under the control of tho h1Btocompat1bi'ity~linkBd Ir genes,
would be blocked by antisQt'a directod against the
histocompatibility spocificities (Shevach at a7., 1972).
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This indicated that products of the major histocompatibll 1ty
complex expressed on the surface of the cells were important in
macrophage~antigen-T cell interaction.
The histocompatibility-linked Ir genes regulate the response of
cells to thymus dependent antigens and this control was thought
to be regulated at the level of the T cell (Mitchell at a7'1
1972), however Shevach & RJsenthal (1913) effectively
demonstrated that the macrophage expressed the It' genes 'thus
suggesting that this was the cell ~Ihich determined T oal l
responses. That the Ir genes control the response to Certain
ant1g8nS was shown by Levine at 117. (1963) where the
response of outbred guinea p'lgs to poly-l-1ysine homopolymer
[dinitro phenyl (DNP)-PLL) proved to be under the oontr01 of a
single autosomal gena. similar centro! was shown for 'more
conventional antigens, such as insulin (Sarc1nsk1 & Rosenthal,
1977) where different stains of guim\lli pigs were shown to
recognise and respond to different portions of the insulin
mol~cule.
The availability of inbrod strains of mice and guinea PiSs
permitted the rapid mapping of the Ir senes, The mouse immune
response (II') genes were mapped by genetic recomb1nation to the
MHC between the K and D lOCi (Figure 9) and the region was thus
namad the I r0910n for immune reponse (Stmpeon I 19(8). The
equivalent region in man is the Class :n MHO or HL~~D re9ion
(Figur'e 10) (t rowsoale , 1988), EVen after discovering the
mappin& to the same region of the Ir genes and I region encoded
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cell surface antigens, the relationship between the 2 remained
unclear. It was hypothesised that the Class II in man, or
immune associated (Ia) anitigens 'Inthe mouse, were products of
the Ir genes (Flavell at a7., 1985). La Maur at a7.
(1985) proved this by showing that transfer of cloned Class II
genes into transgenic mice could turn a non-responder strain
into a responder one.
The interaction of macrophages with T cells has been sUgge~ted
to be either in the form of a trimolecular structure with Ia and
antiSM binding to the T cell ;ndependent1y of one another with
Ia serving to stabl1 isa the structure (Herber-Katz at a 7"
1983; Marfack & Koppler, 1987; Shimonkewitz at a7., 1983) or
that antigen and Ia interact physically before or after
encountering the i cell receptor (Orey & Chesnut, 1985). As
hypothesised by Benacceraf (1918; 1~81) it was 0ernonstrated that
the T cell receptor recognises an ant1gen"'II:\comp1ex and that
the antigen binds to the 11.1 molocule on the antigen presenting
cell (APC) (Babbit et a7., 1985; Buus at a1., 1986).
,'he argument against this was that there was only a limited
rumber of different Ia molecules which had to inte, :It with a
myriad of antigens (Grey & Chesnut, 1985). If, however, the
binding site for antigEln were only a few amino ac+ds long (as
!~u9gosted by Benacerraf, 1981), many orotetns would be ab'e to
bind to th0 G8me Ia ~~lacule. Gr8Y et a7. (1989) identified
7 papt tdas from unre lated proteins which bound to lAd and
showed that these a11 had a core reg ion of a ami no acids wh ich
were Similar to a sequence found rn (,'lora 327-332 shown to be
critical for l'inding ('ITthe latter to lAd,
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Figure ~ Structural genes for the Mouse Major Histocompatibility complex.
(Adapted from aarrett. 1988)
Centromere HLA
o
HlA HLA HLA
B C A
I
I I I \
I I I \'
I I I \
I I / \
'-D--O-Lj-- I -m-~~-1Zr
\. pp .. "y. 00) '-.:: CY4-2.Sf,)., ,
Class II Class III Class r
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Further studie:o have ;hown that Ia can present a large
fragment of antigen which does not need further proteolytic
cleavage, for example hen-egg white l},sosyml:)(HEL) peptide 40-13
could be presented by IAK ArC in spite of the amino acids on
either side of the 52-81 binding seqUence being present and
extending beyond the binding site (Oonermeyer & Allen, 1989).
Further proof of MHo-antigen interactions was provided by Grey
at aT. (1989) who showed that acid treated Class II MHC
(purified from B cells) released peptides which could later
recombine to the MHO molecules and Srinivasan & Pierce (1990)
isolated a functional peptide-MHO complex from APe's.
Whether interaction of the antigen with Is occurs on the
membrane or in the cytoplasm of the macrophage is not certain,
but recent ev1dence (Leyva-Cobian & Unanue, 1988) suggests that
it is a cytoplasmic event and that the la-antigen complex is
then car-ried to the cell suri:ace. Oonermeyer & Allen (HI' '1)
have lent support to such a theory by dElmonstrating that once
bound to ta, an antigen becomes resistant to further' proteo1ytic
cleavage. This complex, foril1edin intermodiary vess te'les in the
cytoplasm will be transported to the cell surface where it will
then be accessible for recognition by a T cal I. Thei r studies
also suggest an explanation of the degree to which antigen
degradation within cells occurs. An alter1ative mechanism
suggested by Fa 10 at a7. (1!~a$) is that processed ant is' "
bind to pnospho ltp'td or other carrier molecules, a rEI transported
to the cell surface and then interact with Ia.
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stock inser et Ii1. (1989) showed a requ irement of a vari ant
chain fragment of la for antigen processing. [The invariant
chain (Ii) fragment is a 31kDa chain which complexes with the
polymorphic Ia molecule shortly after it~ ~iosynthesis in the
endoplasmic ret iculun (Simonis at a 7., 1989).] Fibroblast
ce'1 lineS which express la molecules but do not have the Ii
chain, ara incapable of presenting native antigen (Shastri at
87., 1985). If these lines are transfected with the invariant
chain gene, however, succossful antigen prasentatic.t can then
take place (Stockinger et a7., 1989). Although tho detailed
steps involved in this process have not been elucidated, the
antigen would be ondocytosed, fragmented to peptides and would
then interact with Ia (Stockinger at 87., 198B). The Ii
chain could facilitate binding of the antigen fragment at the
appropriate juncture of the Ia moleCUle. The inVariant chain
could also participate in intracel1ular transport and reoycling
of antigen to the cell surface (Simon1s at aT., 1989).
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2. TUBERCULOSIS
2.1. INTRODUCTION
Tuberculosis, an infectious clisease caused by Mycobacterium
tubercu7osis, is still a major communicable disease especially
in developing countries (Wadee, 1989; Schmidt, 1989). In
industrialiserj countries, such as the USA, there has been a
rapid decline in the cases of tuberculosis reported amonsst the
caucasoid population but among other minorit.y groups the decline
has been much slower (Snider, 1989). The average annual d~cline
rate in the USA has dropped from 6.1% for the period 1981-1984
to a 0.4% decline rate for 1987-1988 (MMWR, 1990). An increased
incidence of tuberculosis amongst inmates of correctional
institutes in the'USA has recently been noted (Snicler & Hutton,
1989; Braun et a7., 1989). It has b~en suggested that this
may have an impact on the incidence of tuberculoate \'ocuring in
the community into wh'lch these inmates will be released (Snider
& Hutton, 1989).
Although there has also been a decline in the incidence of
tuberculosis in England, which is ascribed partly to successful
SeG vaccination, tuberculosis is stil1 frequ~ntly seen among
children, especially those Qf Asian and West Indian origin
(Silverman, 1988). The incidence in these communities living in
the UK is estimated at 40/100 000 and 17/100 000 respectively
(Silverman, 1988).
Although tuberculosis ~as always had a bimodal age distribution,
occuring in ~oung children and older people, an increased
incidenG9 is now being seen in the 24~44 year age group (Bass,
1989). This is the same age group which has an increased
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incidence of acquired immune deficiency syndrome (Aids) (Bass,
1989). Current evidence points to a very strong risk factor in
immunosuppressed individua1s for the progression of latent
tuberculosis to clinical disease (Selwyn at al., 1989;
Quinn, '(989). This is particularly true in the case of patients
with Aids in whom infection with the human immuno-deficiency
vi rus (HIV) is associated ~/ith immunosuppression.
In developing contries an even greater problem exists. It is
estimated that approximately 3~4 million new smear-positive
(pulmonary) and another 3~4 million smear~negat1ve (extra-
pulmonary) tUberculo~is cases develop anually (stybl0, 1989).
About 2-3 million people in these countries die Of tuberculosis
avery year (stybl0, 1989). This occurs in spite of extensive
attempts by the World Health organisation to control
tuberculosis (styb'lo, 1989). The reasons for i'ai1ure of the
tuberculosis contro1 program tn tljt3sedeveloping countries are
many, These include an inadeQI.,<'l.tediagnosis of the sources of
inf~ctlon (i.e. people with smear-positive pulmonary
tuberculosis) and a chemotherapeutic regimen that is diff1cult
to institute successfully (Styblo, 1969). Since therapy for
tUberculosis is a prolonged process, lasting from 6-12 months:
compliance is poor ~nd l~ads to treatment failure and drug
resistance (snirler, 1989). Another factor which may affect the
irradication of tuberculos1s in such countries is the high
incidencQ of patients with Aids. In Africa, unlike Europe,
where tuberculosis has B bimodal age distribution, Africa
demonstrates a high incidence of individua1s between 20 and 50
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years of age infected wi~h the tUbercle bacillus (styblo,
1989; Bass, 1989). A relatively high proportion of them are
exposed to a substantial risk of exogenous primary infection or
reinfection with the tubercle bacillus owing to the high
incidence of tuberculosis and to the immunosuppression t'esulting
from AIDS (Quinn, 1;~89). It is therefore inevitable that the
absolute numbers of cases of tuberculosis will increase in
developing countries were Aids is a major health problem
(styb lo, 1989).
In south Africa current estimates of the incidence of
tuberculosis, based on notifications, range from 206-269/100 000
(London, 1989). Ho\"ever, an increased incidence is currently
being noted in certain areas of the Cape (London, 1989), In
spite of effective diagnosis and treatment, the prevalence of
tuberculosis among black miners in South Africa is still very
high with an incidence in the or-der of 500/100 000 (cowie ,
1989). A reason fa' thts high rate of tuberculosfs may be tha.t
infected 1ndivinuals do not present themselves for treatment and
therefore contribute to the perpetuation of the disease in the
worldng popu lat lcn and thei r home area (Benatar, 1982). Another
reason for this high rate of tuberculosis is the migrant labour
system. Infected miners who become ill oft~n return home and
the disease is easily spread among the extended family and
community where medical facilities are often scarce (Cowie,
1989).
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It is therefore essential that improved diagnostic techniques,
effic'lent therapy regimens and more effective vaccines be
deveioped if tuberculosis is to be 'Irradicated (Schmidt, 1989).
A more comprehensive knowledge of the host-parasite
relat.tonehto: the chemistry and functional role of mycobactar+a'l
antigens in dise~se processes and the regulation of the immune
response to tnese antigens ma:', theraforp provide new avonues
for the tr8atment of tuberculosis (Wadee, 1990),
2.2. TUBERCULOSIS: THE DISEASE
Tuberculosis is a chronic infectious disease of long durat.ton
in human, beings that is caused by Mycobacterium tubercu10sis
(Youmans, 1986): It is usually acquired by inhalation of
droplet nuclei containil19 the tubercle bacilli. The droplets
are spread from person to person when infectious material is
discharged into the air by coughing or by other means (Farer,
o
1979). The usual portal of entry is the lower respiratory tract
whets these particles can reach the most peripheral portion of
tne bronchial tree and can lodge in the I;\lveollwhere a focus of
infection can be established (Riley, 1974). Although the
a1 rbcrne route is the main route of transmission, tuberculosis
has also been'shown to be transmitted v.ia the gf.lstro-intestinal
route or by direct inoculation through the skin or mucous
membranes (Farer, 1919).
;.
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Pulmonary tuberculosis accounts for approximateiy 85% of all
the tuberculous cases (Steigbigel j 1979). The symptoms may
range from asymptomatic individuals to those with fever, weight
10ss, productive cough, haemoptysis and extensive infiltrates
with cavitation in the lung (ste;gbigel, 1979). The first
<.;'linicallyevident manifestation in man is a granulomatous
nodule termed the Ghon focus (Grange, 1980). The centre of the
granuloma fuay often contain necrotic tissue of "cheese-like"
appearance (caseation), surrounded by lymphocytes and
macrophages (Grange, 1980). Non-healing primary foci in the
lung enlarge ana the caseous centres frequently liquefy.
Discharge of this "Iquified material by ulceration into the
pleural cavity leads to pneumonia (Grange, 1980).
During the progression of the primary disease, the tubercle
bact l lus can spread to dtstant sites resultirg in tuberculosis
of the liver, spl~en, kidneys, Central nervous system; joints,
bone: bone marrow, pericardium, peritoneum, intestine or
genito-urinary tract (Stetgb1gel, 1979).
Miliary tuberculosis is'a disseminated form of the disease
characterised by a diffuse miliary pattern of tUbercles
distributed in many organs of the body (Grange, 1980), The
symptoms of this form of tuberculosi~ are usually non-specific.
Weakness, .anorex ia, f'at tque , weight-loss and fever are V~I"y
conmon. Cough is seen in 18-65% of patients, while headaches
and abdom1nl'.1pain often ref1ect invo1vement of the central
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nervous system and intestinal tract respee;tive1y (P~oudfoot,
1969). Predisposing factors for this form of d+seasa include
a 1coho lt sm, pregnancy, neap 1sst; c d iseas a and parents 1 drug
abuse (Hunt, 1971).
2.3, THE IMMUNOLOGIC RESPONSE TO
MYCOBACTERIUM TUBERCULOSIS
.'
The earliest reactions in primary tubercu10sis are unknown but
data accumulated from animal studies indicate that an acute
inflammatory reaction occurs in the tissues early in the
infection sLic..hthat organisms are pha )cjtosed by
polymorphonuclear leukocytes (Lucas, 1988). These cells are
replac8a by atvso lar macrophasas and by macroohasas which mature
from monocytes circulating in the hlood stream (Dannenberg,
1982). Both cell types'are attracted to the site by released
bact lli , cellular debris and a variety, of chemotactic factors of
host origin such 8.S the complement component C5A (Dahnenberg,
1989) Macrophages apparently differ in their ability to kill
invading mycobactRria (Danneberg at s7., 1963). Resident
a1veolar macrophages do not I<ill the invading mycobacteria,
either because they remain at the periphery of the lesion far'
aWay from the baCilli in an established 1es;on (Dannebers, 1989)
or because they have an inability to kt l],the virulent tubercle
baci11us once it has been ingested (Col1iQs, 1989), Blood-
•derived monocytes which emigrate to t.he leas;on, are activated
by lymphokines and can then kill the bacterium CWiegeshau$ at
a7., 1989). These c~lls are therefore completely responsibl.
for the fate of the early lesion (Dannebers, 1989).
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In the ear1y lesion the tubercle bacillus and the macrophage
live in a state of symbiosis (Danneberg, 1989), In 2-4 weeks
this balance, however, is disturbed'with thE'. gradual development
of a specific immune reponss (Danneberg" 1989). Macrophages
become activated by antigen-specific T cells or lymphokines
released i.ly th"Jse cans, and have an increased abil ity to
destroy the tubercle bacillus (Ando et p7., 1977). At the
same time many of the macrophaqes are killed either by the large
number of multiplying bac i l l t anr' their products' or by direct
cytotoxic action of tile bacterium itself (Lucas, 1988). A
tuberc la thus forms that consists of a caseous necrot tc centre
surrounded by a lymphocyte mantle consisting mainly of T,
suppressor cells (Van den Oord,et «t., 1984), some
macrophaqes and other cal ] types. These T suppressor cells may
have an important role to pla¥ in the cellular unresponatvenese
which devs lops in animals and man (Watson s Collins, 1980).
Recent evidence in favour of this indicat~s that macrophages
which have phagocytosed mycobacteria release suppressor cell
s..:;dvating factor (SCAF) resulting in activation of suppressor
mschantsms locally (Wadee 11Rabson, 1981; Wadee et 8.7.,
191:13) •
Even though the pathossnes ts of caseation in tuberculosis is not.
clearly understood, se' anl'l factors are thought to contribute to
its formation (Dannenberg, 1989), viz. high concentrations of
lymphokines prod,lcE'ltiin response to a tuberculous inf~ction by T
(and possibly B) lymp!1oGytasmay be toxic to the tissues; large
amounts of toxic components of t.he mycobacttlrium could be
50.
released during the bacterial breakdown process resultih9 in
tissue damage (Dannenberg, 1989); ischaemia from thrombosed
blood vessels could cause infarction of tho area (Courtade at
87., 1975); act tvat ton of t.he ccnp'lement path\,Jay might damage
host cells in the area; hvdrctyttc enzymes and reactive oxygen
radicals released from 1ive and cl'isintel"grating macrophases
might directly injure the surr ..unding tissue; and the
mscroohases m'lght release monoktnes suer as tumour necrosis
factor (TNF) \·,hich maYalso damage the surrounding tissues
(Damu nberg, ~982; 1989; Lucas, 1SSa).
~Ihether the granuloma progresses or regressos depends upon the
ability of the macronhases ent¢3ring the graliulating tissue to
destroy the invading organism (Collins, 1989). ~1inute caseous
foci can probr"ly be eliminated by surrounding macrophases
(Dannenberg, 1989) but largsr foci (5-20m.'1l)cannot since
maerophagas cannot penetrate very far into the CaS(IOUS centre
(Courtade et a7" 1975). These foci probably undergo
fibrous encapsu1ation and are isolated within the host (Grange,
i980). It is these, iarge foci l'lhich may be reactivated years
tater as a rssutt of ;mmunos'JPpre~,sion due to a variety cf
reasons such as stress, steroid therapy or cancer chemotherapy
(\'liog9shaus et el ., 1989).
Liqueficatiun of the caseous centre of the tubercles is one of
the most harmful responses in this diseaso (Dan"eberg &
SlJgimoto, 1976). It occurs as a result of hydrolysis of the
protein, lipid and nucleic acid components of caseous tissue by
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the hydrolytic enzymes of macrophages (and perhaps
granulocyt~s) (Weiss & singer, 1953). The liquefied caseum is
an excellent culture medium for the organism, which will now
multiply extracellularly resulting ;n a large antigenic load.
This will cause an over st tmutat to.t of the delayed type
hypersensitivity response of antigen-specific T cells. This
response, which in the presence of low concentrations of
bacillary antigen is beneficial, ",till, in the presence of high
concentrations of antigen, result in cell death and tissue
destruction (Dannenberg, 1,82). The walls of nearby bronchi
often become necrotic, rupture and form a cavity. The bacilli
and small amounts of liquefied tissue can now be discharged into
the airways and reach other parts of the lUng and environment
(Dannenberg, 1989). T~e organisms maY now spread to various
organs without any apparent clinica~ man1tE:l':)tations(Farer,
1979). Intensive dissemination of the organism by the
haamatogen;c route cah thus result in serious disease such as
tuberculous meningitis and miliary tuberculosis, represented by
small lesions spread thoughout the body (Ivanyi, 1986).
During the primary infection there is clonal expanston of
antigen-specific T cells Which, on re-exposure, rapidlY produce
lymphokines and thereby acce1erate macrophage activation and
accumulation at the site of infection (orme & col lins, 1984).
As a result, the lesions remain small and heal rapid1y such that
secondar}' tubercles of either haematogeno'Js or lymphogenous
origin usually do not progress in immunocompetent adult humans
(Dannenberg, 1989). Factors which predispose to post-primary
,"
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infection include:- a£9, ~oncommitant diseases (e.g. Aids),
hormonal changes (e.g. pregnancy) and immunosuppressive therapy
(e.g. in cancer) (Farer, 197~).
2.4. THE ROLE OF THE PHAGOCYTE IN
TUBERCULOSIS
On coming into contact with the tubercle bacillus, the
polymorphonuclear cells and macrophages will ingest the organism
(Martin et 137., 1950; Dannenberg, 1982; Brown at 137.,
1987; Rook. 1988; Wiegeshaus at 137., 1989). The uptake of
the mycobacterium requires initial contact between the organism
and specialised structures on the membrane of the cells that are
capable of triggering the phagocytic process (Piessens, 1989).
The first cells to arrive at the site of infection are the
neutrophiis which will become 'activated' and ingest and degrade
the flrganisms (Brown et 87., 1987). These phagocytes
therefore play an irr.'Oortantrole in the early phases of
infectioTl, and are then replaced by alveolar macrophages and
macrophages emigrating from the circulating pool of mcnocytes
(Dannenberg, 1989). In addition to degrading the invading
organisms, the macrophage also presents the processed
mycobacterial antigen on its surface, in contaxt with host MHC
Class II molecules to helper T lymphocytes (De Vries, 1989;
Bhardwaj & Co1stan. 1988). The T 1ymphocytes will respond to
this specific antigenic challenge by undergoing Cl0l"Ki1
oro liferation and producing Iymphokf nes (Dannenberg, 1989). The
lymphokines will then further activate the macrophages and
enhance thei r tuberculocidal capabilities.
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Even though the existence of several adherence receptors have
been demonstratod on phagocytic cells; mannose-fucose (Wilson &.
Pearson, ·1981j);complement receptors CR1 and CR3 (Payne &
Horwitz, 1987); Fc receptors and leukocyte function associated
antigens such as LFA-1 and LFA-3 (Springer at a1., 1987),
the exact receptor involved in promoting the entry of the
tubercle bacillus into these cells is not known (Petssens ,
1989). Th3re is, however, some evidence from in vitro
studies on human monocytes which indicates that the CR1 and CR3
receptors on the monocyte mediate the phagocytosis of the
bacillus (Schlesinger et a1., 1990). Once the organism has
bound to the surface of the phagocyte, the plasma membrane will
invaginate into the cell and close off around the organism
forming a phagosome (legrange et a7., 1~83). consequently
the phagocyte undergoes activation and will exhibit ~rofound
morphological changes. The ce I1s now demonst.;dt9 an increase in
surface area, ruffling of tne plasma membrane and randOm
migration (Grange, 1980). There i~ also an increase ;n the
number of mitochondria and lysosomes, an increased metabolic
activity, increased phagocytic ability (especially for antibody
or complement coated particles; Grange, 1980) and increased
tuberculocidal capabilities (ArmstrOng & O'Arcy Hart, 1971;
Wades, 1990). Within the cytoplasm, enzyme containing lysosomes
fuse with the phagosome, forming a phagolysosome (Sharma,
1986). Lysosyme and other hYdrolytic enzymes are released by
lysosomal granules and wi,.., exert their digestive activities on
the lngested organisms (Mitchhon et a7., 1963). In
addition, toxic oxygen radicals, such as hydrogen peroxide b."f
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superoxide anion, are produced by the respiratory burst which
accompanies phagocytosis (Paton & Ferrantc~ 1983; Klebanoff &
Harmon, 1975; Mitchison at a7, 1963).
2.4. L Macrophage Activation by
Lymphokines
The lymphokines released by the T lymphocytes have been shown
to enhance macrophage function (Nathan et 87., 1983). Crude
supernatants from anti8en or mitogen stimulatea lymphocytes have
been shown to augment antimicrobial activity (Fowles et a1.,
1973); enhance HMPS activity (Nathan et s7., 1971) and to
enhance the secretion of chemically reactive reduced metabolites
of molecular oxygen (I'lakagawaraet a7., ;982).
The best characterised 1ymphokine with macrophage activating
function (MAF) is IFN-gam~ji;.i(Nathan et a7., 1983) and the
effect ~f this lymphokine on macrophages will be discussed in
Chapter 3. other lymphokinas with MAF activity have, however.
been described.
lnterleukin 3 ell-3) or multi-CSF functions as a MAF which
selectively regulates the accessory cell characteristics
required for antigen presentation, rather than the cytolytic
function of the macrophage (Frendl & Beller, 1990). GM-CSF and
M-CSF have been shown to increase the ability of macrophages to
kill l.eishm'fJ.nia. mex icens smszonensis (Ho at 0.7., 1990).
In addition, GM-CSF (together with lL-2 and IL-4) was found to
act as a co-factor for lFN-gamma in activating macrophages for
antimicrobial function (Belosevic et e7., 1988).
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IL~4 has also been shown to induce tuberculostatic potential
in murine bone marrow-derived macrophages which are infected
with M.bovis organisms (Flesch & Kaufmann, 1990).
These lYmphokines may p'lay an important role 'in activat'lng
macrophases for tuberculocidal activity, a1: ~hough the role
played by each has not been determined.
2.5. MECHANISMS OF INTRACELLULAR
SURVIVAL Or MYCOBACTERIA
In spite of the many ir.tn>.(;el1ulardesredat lve mechanisms
demonstrated by phagocytes, many pathogenic organisms and in
particular M.iuberculoeis have the ability to survive and
grow withi n the cytoplasm of these cs 11s {Nathan et: a 7.1
1980). Various escape mechentsms exist which enhance microbial
virulence by interfering with the phagocyte's ability to
recognise, ingest and ki'll the organisms (Densen & Mandel 1,
19S0). These include:-
interference with macrophage activation (Pabst at a1.,
1988);
inhibition or neutra1isation of oxygen metabolite production
(Kusunoso at 87., 1976; Chan at a7., 1989);
inhibition of phagosome-lysosome fusion (Goren et 87.,
1974; Armstrong & D'Arcy Hart, 1915);
disruption of phagosomal membranes and inhibition of
degradat'lon (Hooper at 87., 1986; WaOJ9, 1990).
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2.5.1. Inhibition of Macrophage
Activation
The ability of macrophages to kill mycobacteria depends on
their state of 'priming' or 'activation' (Ando at 87.,
1911). MaCrophages primed in vitro or activated in vivo
produce more oxygen metabo1ites than do unprihled or 'resident'
macrophages when they phagocytose mycobacteria (Dannenberg at
a7., 1972). Agents which cause priming in vitro include
bacterial LPS, muramyl dip~ptide (MOP) and IFN-gamma (Pabst &
Johnson, 1980). However, these agents have been shown not to
di rectly st.tmulate the release of 02-, but rather to prime
macrophages for enhanced release in response to a subsequent
stimulus (Pabst at a1., 1988). Sulphat1de 1 (SL-1), a
tetra-acylated trehalose sulphate is found in the outer ce1'
wall of mycobacteria (Goren et a7., 1982; Pabst at 87.,
1988) and has been shown to inhibit this 'priming' of
macrophage~ (Pabst at a7., 1988), In their experiments
Pabst et el , (1988) showed that SL-1 inhibited severat
parameters of activation including 02- release, phagocytosis
and the release of IL-1. Since SL-i did not directly affect the
NAOPH oxidase enzyne system or inhibit these three functions in
unprimed cells, it is probable that SL-1 affects the processes
that conVert. an unprimed monocyte to an activated macrophage
(Pabst at a7., 1988).
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2.5.2. Derangement of Electron Transport
in the Respiratory Chain in
Mitochondria
Cord factor, or trehalose dimycolate (TOM)I has been shown to
be highly toxic to leukocytes (Bloch, 1960) and to cause a
derangement of the mitochondrial electron tra~sport system in
liver. lung and spleen tissue (Goren, 1912).
Cord factor \lIas originally thought to be responsible for the
tendency of virulent N.tubercu7os1s organisms to grow in
para'l la l cords (Bloch, 1950). This activity of cord factor has
however never been proven (Goren, 1972). Cord factor is a
regular constituent of Wax C in most virulent strains of
ftlycobacter'ia(Noll, 1957). Wax C ecnststs mainly of long chain
fatty acids which are esterified with com!)ounds such as
phthtocero'l , glycerol and trehalose to form 1ipid,'3of a
mi'lecular weight ranging from 1 000 - 300 daltons (Noll, 1951).
oekierkunst & Artlll£lr(1962) showed that cord factor has been
responsible for the attenuation in activity of pyridine
nucleotide (NAO) dependent microsomal enzymes. This occurs
partly due to the detrimental stimulation of nicotinamide
adenine dinuclease activity and the concomitant depressioll in
levels of nicotinamide adenine dinucleotide. In addition to its
effect on the electron transport in the respiratory chain, cord
factor can directly attack the mitc)chondrial membranes resulting
in swelling and breakage of limiting membranes (Kato, 1969). It
is possible that the cord factor could be released from the
degraded tubercle bacilli ~nd attack the phagosomel membranes in
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the same way it attacKS the mitochondrial membrane. Release
of h'!gh concentrations of the cord factor might then result 1n
membrane rupture and intraGolluitli' release of otherwise trapped
virulent organisms (Goren at a7, 1974a).
The final way in which cord factor may cont"'ibute to the
survival of the organism was suggested by Bluth il'l 1950 when he
showed that cord factor inhibited the migration of 1eukocytes
in vitro.
2.5.3. Resistance to Oxidative KillinQ
systems
Following phagocytosis, phagocytes demonstrate an increase in
the oxidative respiratory burst and 1n the activity of the
hexose monophosphate pathway (McRipley & Sbarra, 1967). This
results in the production of H20Z, superoxide anion,
hydroxyl radical an.:Isinglet oxygen (McRipley Be sbarra, 1967)
which ;nay in themselv\'s be directly toxic to bacterin. Their
toxicity may be further enhanced through the generation of more
reuctive molecules (Lowr,e & Andrew, 1988), such as hypohalite
ions (Klebanoff, 1968).
$uperoxide produced by activation of the NADPH oxidase :system
(discussed in section 1.3.3.2.1.) is a highly reactive oxygen
radica.l which is capable of breaking down sugar molecules (Chan
at aT., 1989), The tubercle bacillus, however, seems to be
fairly resistant to this molecule (Jackett at a7., 1976a).
H.tubercu7osts organisms haVe been shown to contain
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superoxide dismutase (Kusunose et a7., 1976) which coverts
suparoxide to hydrogen peroxide (H202) and oxygen (Mandeli,
1975) .
A role for H202 tn killing mycobacteria was suggested as far
back as 1963 by Mitchison et 87., who showed that resistance
of the mycobacterium to H202 was associated with increased
virulence of the organism. ~Iore direct evidence for the
importance of 1-12021n the ki11ing of mycobecteria by
phagocytes i.as supplied by Walker & Lowrie (1981) and Sharp at
a7. (1985). Walker & Lowrie (1981) showed that macrophages
activated with phorbo1 Myristate acetate (PMA) could 1<.111
N.micoti. The addition of exogenous catalase, Iwhich
decomposes 1-1202 to oxygen and water (Mandel', 1975).J
however protected the organism from tnbracal lular killing,
indica\.;ng that H202 was responsible for killing the
organism. Sharp at a7. (1985) provided additional eV;~"Ince
that H20:! played a role in killing li,ycooacter'la. They
snowed that N. leprae organisms, which are catalase negative
and are killed by H20a in vitro are a1so kt lled by mouse
peritoneal macrophages.
Although susceptibility to H202 correlates with low
virulence in many strains of N.tub~rcu7os1s, some
laboratory-attenuated strains retain their resistanc~ to
H20:! (Jackett at et.; 1978a). This implies that
anti-microbial mechanisms other than direct action of H20a
ldll these organisms within the macrophage (,Jackett et et«,
1980). The myeloperoxidase, peroxidase-ha1ide (MPH) system
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(discussed in section 1.3.3.2.2. (c)) has been shown to
augment the bactericidal potency of H20Z by forming
hypohalite ions (Klebanoff, 1968). The MPH system which was
shown to be effective in killing M.tuberouloets used either
iodide or chloride ions as co-factors (Jackett et a7.,
1978b).
The peroxidase content of macrophages has been shown to be very
low in comparison to PMN cells and mcnooytes (Lepper & D'Arcy
Hart, 1976). However, catalase can replace peroxidase in the
killing system, since it can function peroxidatively in the
presence of a low st~ady concentration of HZ02, particularly
in an acid enl/ironment (KlebanOff & Hamon, 1975). Macrophag9s
from various s')urces, [pulmonary alveolar macrophages of rabbit
(Gee et (17., 1970) and rat (Davies et sr., 1979); and
peritoneal exudate macrophages of guinea pig (Simmons &
Karnovsky, 1973)], have been shown to contain catalase. It is
therefore poscible that a catalase, .peroxide, halide system may
substitute for the MPH systum which operates in po1ymorpho~
nuclear cells and monocytes (Klebanoff & Hamon, 1975). Catalase
reacts with H202 to form an enzyme-substrate complex which
reacts with a second molecule of H202 to form oxygen and
water (Mandell, '1975). When the H202 is maintained at a
very low steady state concentration by a H202-generl'l.tlng
system; a number of substances, including thyroid hormones and
iodide ions, can succrJssful'y compete with the second mo'lecule
of H202 for oxidation by the catalase-H202 en~yme-
substrate complex (Klebanoff & Hamon, 1975). It is under these
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conditions that a microbicidal effect is seen (Klebanoff &
Hamon, 1975). Jackett at a7. (1980) showed that the
catalase, halide and hydrogen paroxide complex was toxic ,0
H.tubercu7osis in vitro, but that susceptibility to catalase
mediated killing did not correlate with the virulence of the
organism.
In contrast to macrophage derived catalase, the presence of the
enzyme within mycobacteria has been sugsested to have a
protective effect for the organism (Lowrie & Andrew, 1995).
Catalase from the tubercle bacillus can decompose H202 to
oxygen and water thereby neutral ising the toxic effect of
H20~ (Mandel', 1975).
Althouah most strains of N.tubercu7osis have been shown to
posseSS catalase, a few strains ara devoid of the enzyme
(Whealer & Ratledge, 1988). It is of interest to note that
these 1atter strains are more susceptible to the lethal effects
of peroxtde and are usually less virulent than strains that
contain catalase (Lowrie, 1983). Nevertheless these strains
lacking catalase and N.leprae (which has no catalase) are
still pathogenic organisms. It is therefore possible that the
production of toxic oxygen metabolites by the host is not by
itself sufficient to kill mycobacteria. It is also possible
that pathogenic mycobacteria have other ways of evading toxic
oxygen metabolites (Whoeler & Ratledge, 1988).
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One such chemically defined mycobacterial component that
protects mycobacteria from oxidative degradation is the
lipophilic cell envelope of the organisms (Wheeler & ~atledge,
1988).
chan et el , (1989) showed that Ue phenolic glyc()lipid I
(PGl) of M.7eprae in infected cel ls and tissues may protect
the mycobacterium from oxygen radical damage. PGl is a major
constituent of the ult.rastructurally observed electron-
transparent zone surrounding the bacillus (Hunter & Brennan,
1981) • Thi s zone acts as a scavenger of oxygen radt calsin a
cell free system (Hunter & Brennan, 1981). G\)ren et: et,
(1974b), while studYing a series of attenuated strains of
N.tubef'cu7osis, identified one common structural feature
that distinguished them from the more virulent strains. The
factor was termed 'attenuation indicator 1ipid' and was shown
to be a phenolic phthiocerol diester. Yhis molecUle has a
structure very simi lar to a synthetic altered form of PGr
produced by Chan at tiT. (1989) which was shown to be unable
to scavenge OH-. /!.ttanuatedstrains of the tubercle bacilli
may therefore haVV3all its surface lipids altered in such a WaY
that they are unlble to scavenge oxygen radicals and are
consequently killed (Chan at al'j 1989).
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2.5.4. Inhibition of Phagasome-Lyso1ome
Fusion
H.tubercu7osis has been shown to escape intrace1lular
degradation by preventing .'~agosome-lysosome fusion (Armstrong &
D'Arcy Hart, 1971). Several mechanisms have been suggested to
explain this phenomenon (Rastogi & David, 1988). By coating the
surface of the tubercle bacillus with specific antiserum prior
to phagocytosis, reversion of non-fusion was observed (Armstrong
& D'Arcy Hart, 1975). Later studies by Frahel & Rastogi (1987)
showed similar results using H.1eprae. This would indicate
that the surface propartles of the bacteriUm are responsible for
inhibition of phagosome-lysosome fusion. The exact nature of
the surface-related inhibitor still rematna unknown but the
possibilities are that either the mycobacterium produces a
'fusion inhibitor factor' (Armstrong & D'Arcy Hart, 1975) or
that the su'lpholttrids in the outer layer of the bacteri,Jm are
themselves inhibitory (Goren et a1., 1974a & b; 1916).
These studies by Goren et al. show that tha presence of
strong1y acidic lipids in virulent strains of the tUbercle
bacilli are responsible for the inhibition of phagosome-lysosome
fUSion. Later stUdies by Rastogi & David (1988) confirmed these
findings by demonstt'ating the presence of strong1y acidic
S042~ groups present on the surface of the H37Rv strain of
the tubercle bacillus but not on the avirulent strain, H37Ra.
The tubercle bacillus produces other substances which may playa
role in inhibiting phagosome-lysosome fusion (Rastogi & DaVid,
1988). One such molecule is cyclic-adenosine monophosphate
(cAMP). Lowrie et a7. (1975) have shown a marked elevation
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of cAMP 1n macrophages ingesting live M.microti but not in
those ingesting dead organisms. They ~howed that cAMP was
released by the bacterium into the phagosome and that this
release inhibited phagosome-lysosome fusion.
Alntnoniaproduced by mycobacteria may also cause inhibition of
phaaosome-lysosome fusion (Gordon at 87., 1980). This group
showed that culture filtrates of M.tubercu7osis inhibit
fusion of yeast containing phagosomes with lysosomes. Their
studies effectively demonstrated that the inhibition was caused
by ammonia present in the c lture filtrates. Although ammonia
has been shown to raise tnt.ratvsoscnal pH and to 1nhib"ltthe
deyradation by lysosomal proteins, it is unlikely that its
inhibitory action on phagosome-lysosome fusion operates thi'ough
interference with PH and protein metabolism (Gordon et: 87.,
1960). This is borne out hy studies using chloroquine which
demonstrata similar effects on PH and protein metabolism but
with an enhancement of phaUDsome-lysosome fusion (Gordon at
a 7., 1980).
A third factor which 1S thought to causa inhibition of
phagosome- lysosome fusion is the presence of polyanionic
compounds (Rastogi t David, i988). As discussed earlier, Goren
et a7. (1976) showed that strongly acidic sulphated
9lycOlipids found on the surface of the tubercle bacillus were
able to induce inhibition of phagosome-lysosome fusion. This
was seen both in experiments where the sulfatide was ingested by
the phagocyte prior to exposure to yeast, and in experiments
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where yeasts used to assess phagosome-lysosome fusion were
coated with the sulfatide (Goren et a7., 1976). To
ascertain if the effect of the sulfatide was due to its
polyanionic nature, several in vitro studies were performed
using polyanionic substances. Draper et a7. (1979) showed
that both suramin and poly-alpha-D glutamic acid (1ysosomotropic
polyanionic substances) could inhibit phagosome-lysosome fusion
in macrophages ingesting H.7epraemurium, an organism which
does not normally inhibit phagosome-lysosome fusion.
Macrophages pre-treated with suramin (D'Arcy Hart & Young, 1975)
or poly-alpha-D glutami~ acid (D'Arcy Hart & Young, 1978) also
showed inhibit iat) of phasosoma-) ysosome fusion fo11owins
ingestion of yeast. These studies all seemed to indicate a
possible role for these polyanionic agents in preventing
phagosome-lysosome fusion in magrophages infected with
H. tuberculos is, More recently Goren et 87. (1987) have
refuted this hypothesis. These authors suggest that the
polyanionic agents concentrate in lysosomes as a gelatinous,
sluggishly moving mass that physically entraps particulate
electron opaque markers or the acridine orange in a matrix that
may not transfer to phagosomes for many hours. Lowrie (1988),
however, suggests that this may have resulted in an
overestimation of the inhibitor, effects of the po1yanion1c
agents, but that "the rea1ity of the phenomenon itself does not
seem seriously threatened by thes considerations".
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2.5.5. Modulation of Lysosomal pH
The ability of intracel.ular pathogens to alter pH levels
within phagosomes provides an effective mechanism for bacteria?
survival within the host cell (Black at a7., 1986; Horwitz &
Maxfield, 19134). This would result in a decrease in the
hydrolytic activity of lysosomal enzymes and a probable
impairment of fusogenic: activity of the phagosome with lysosomes
(Kielian & Cohn, 1980)" Chicurel et el . (1988) showed that
a culture filtrate protein extract (CFPE) from
H.tuberculosis reversib'ly increased macrophage lysosomal
pH. They suggested that an inhibition of phagosome-lysosome
fusion mediated by a direct effec~ of the CFP~ on the lysosome
rather than on the phagosome would be a probable consequence of
this alkalinisaticn (Chicurel et al., 1988).
2.5.6. Electron Transparent Zone
An additional protective n,,,,,,,,lanismadopted by mycobacteria is
the formation of an 'electron-transparent zone' (ETZ) following
phagocytosis (R(\stogi & David, 1988). This El'!ccnststs (,.,
c-mycos ides (pept idoglyeo 1ipids) and has been show~1 to deve lop
around various mycobacteria following their ingestion by
-aacrophages , These include, M.avium (Draper, 1974);
M.7epra8 (Frehel & Rastogi, 1987) and M.1epraemur1um
(D'Arcy Hart at 81" 1972). The 1ipld-rich zone interferes
with the E\,bi1ityof the phagosome to fuse with the lysosome.
This is apparently due to the direct interaction of the lipids
in the ETZ with the lipids of the phagosome membrane (Lowria,
1988). It has also been suggested that the ETZ may function by
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preventing the hydrolytic enzymes from attacking the cell wan
of the ~ngulfad mycobacteria by preventing the normal diffusion
of the enzymes, irrespectl ve of successful phasosome-I YSOSOllle
fusion (Rastogi & David, 1988). Tho 1iplds in the ElZ are also
a possible site for harmless pe~oxidation by the reactive oxygen
metabolites produced by the phagocyte, thereby protecting the
inner bacterial cell wall from the ravages of these lethal toxic
molecules (Wheeler & R[I ledge, 1988). However studies
undArtaken by Frehel at al. (1986) showed that following
phagocytosis only 7-15% of H.tubercu1osis formed the ETZ,
whereas as?;; of J·,avium did so. This implies that a1though
the ETZ may be important in protecting some species of
mycobacteria, it is not a"l important protective mechanism for
the tubercle bacillus (Rastogi & David) 1988).
2.5.7. Interference with Anti~en
Presentation (T Lymphocyte
Activat:ion)
As discussed in section 1.4 .. an imporhnt function of the
marcrophage is to activato T 1ymphocytes (antisen~specif1c ca'l~
mad; ated response) (unanue, 1972 ; Rosenthal e.~a7., 1975).
For activation of these cells to occur it is essential that the
macrophage process mycobacteria1 antigens and then present them
in conjunction with Ia (or DR antigens) to the I' lYmphocyte
(Bha~dwaj & Colston, 1988). Mycobacteria may act at this lev~l
by interfering with the antigl:.tnpr9!~enting process (Ivanyi.
1986). It is possible that poorly degradablo polysaccharide or
glycolipid constituents pors1sting in tissues for lon~ periods
after the killing and disintegration of the organisms could
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selectively modulate the la-associated events of epitope
presentation (Ivanyi, 1986). In this context, arabinomannan,
purified from culture filtrates (.)1' N.tubercu7osisJ was shown
by Ellner & Daniel (1979) to suppress ant~gen dePendent
lymphocyte prol iferation in vitro, This suppression was
shown to oc.cur by a disruption of the functional interaction of
antigen bearing macrophages with antigen specific lymphocytes.
Sibley et a7. (1990) demonstrated that pre-incubation of the
macrophages with lipoarabinomannan, a major constituent of the
outer cell wall of the mycobacterium species, blocks activation
of the macrophage by lFN-gamma. These authors suggest a
blocking of lFN-gamma signal transduction withIn the cell at
some point after receptor occupancy leading to an inhibition of
Ia expresaton and a blocking of mecrophase activation. Wadee
et a7. (1983) also showed the mycobacter1a~ phospholipids,
re1eased by the macrophages following degradation of the
bacterium, activates suppressor cells that non-specifically
suppress lymphocyte proliferation to antigens or m1togens.
Furthermore, monocytes derived from tuberCUlous patients have
been shown to express significantly lower amounta of Ia on their
surfaces (E11ner, 1986). This has been correlat.ed with the
suppressed mononuclear c~11 responses to antigen (PPO)
stimulation. In vitro culturing of these cells for 24
hours, however, appears to restore the expresion of Ia on these
cells. It has been suggested that the expresion of Ie in
vitro could be due to regeneration of these molecules (Ellner,
1986). A further explanation has been suggested by Tweardy at
a7. (1984), who postulated that immature Ia- monooytes may
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have a distinctive immunoregulatory ro1e. This is particulary
plausible in light of the studies of Pterras & Germain (1978)
who demonstrated 'immunosuppression mediated by ra- ~el1s.
E''1'·dence also indicates that a raised bone marrow production of
monot~ytes and oar1y release of monocyte precursors may be
responsible for the raised number of ta- monocytes (::".ihm1tt sf;
«t., 1977).
For more efficient functioning of the macrophag9s, activation of
these culls occurs via a lymphokine, IFN~g~Aa, produced by T
lYi.•phocytes (Nathan et er., 1984). These aetivatad
macrophages have enhanced m1eroblcidal activity and express more
In on their' surface (Nathan sf; at., 1983; King & .ronaa,
1983).
By preventing Mtivation of the antigen specifio arm of the
iMmune response and by inhibiting tho intracellular kill1na
capacity of phagocytes, the mycobacterium has produced an ideol
envtronaent for its growth and multiplication.
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CHAPTER 3 ..
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3. INTERFERON
3.1. INTRODUCTION
Interf3rons were first characterised as substances that
inhibit virus rep1ication but have subsequently been shown to
have an effect on many components of the immune system (Morris,
1988). Interferons are classified into 3 types, alpha, beta and
gamma, according to their antigenicity (Morris, 1988).
IFN-alpha and -beta are vary similar to each other, both
biochemically and biologically, and are probably produced by
most viral'y infected ca11s (Morris, 19(8).
The different IFN-alpha mo1ecules have molecular weights ranging
from 18 to 23 kilodaltons (kOa) and are not glycosylated
(Oppenheim at a7., 1981). IFN-beta has a molecular Weight
of 23kOs and is ~lycosYlated; !FN-gamma has a molecular weight
ranging from 20 to 25kDa and is also glYcosylated (Oppenheim
et: a., 198:).
3.2. GAMMA-INTERFERON (lPN-GAMMA)
IFN-gamma (or 'immune interferon') has, over the past few
yearsl become recognised as the major product from lymphocytes
that alters phagocyte function (Schaffner & Rel1stab, 19S5;
Nathan et a7., 1983; Morrison et 4·" 1987). It ha~ been
shown to act as a macrophage and PMN activating factor resulting
in an enhanced abi lity t(. destroy facultative and ob1igate
intracellular parasites and tumours (Adams & Hamiltanj 1987).
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3.2.1. Source of IFN-gamma
Production of IFN-gamma by 1ymphocytes is induced by antigens,
m; togens or the cytol<inas , tumour necros is factor (TNF) I
interleukin-1 (IL-1), interleukin-2 (IL-2) and colony
stimulating factors lBalkwill, 1989). T cells (C03+ cells) have
been shown to be the major source of IFN-garnrna(Kasahara et
a1., 1981). Natural ki1ler (C016+) cells and other IL-2
receptor positive and E rosetting mononuclear ce1ls (which do
not fulfill the criteria for either Teall, B cell or monocyte
lineages), have also been shown to produce IFN-gamma (Sandvig
at a 7., 1987).
3.3. EFFECTS OF IFN-GAMMA
Much of the work done on the activating effects of IFN-gallltn4
on phagocytes has focused on the monocyte/macrophage system.
The dose at which IFN-gamma appears to be effective varies from
<1 to SOOU/ml (Hoover & Meltzer, 1989). This wide dose range
r~portedlY allows for the fine tuning of monocyte responders)
especially in co-operation with other mediators of monocyte
activation (Hoover & Meltzer, 1989). Monocyte stimulation has
been shown to occur Qftar IFN-gamma binds to specific receptors
on the monocyte surface (Celada at a7., 1984). Other
studtes using 1iposomes have 'Indicated that receptor binding
could be bypassed (Koff .~t87.,1985). Wheth'3r the IFN-
gamma receptor is the first element of a sign~l transducing
system or whethe~ the receptor functions as a vehic1e for
transporting its ligand to intracellular raceptors therefore
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remains to be determined (Aguet et 81., 1988). With
regard to receptor-mediated binding, recent evidence indicates
that freshly isolated monocytes bind the lymphokine via a single
type of receptor whereas rnonocytes cultured for 5 days or more
express IFN-ga.mma receptors with two different affinities
(Yoshida et 87., 1988). Once bound, IFN-gamma is rapidly
internalised and results in the activation of a number of genes.
leading to the de novo synthesis of numerous surface and
secretory proteins by the macrophage (Adams & Hamilton, 1987).
Th~se include the production of MHC antigens (Adams & Hamilton,
1987), and the cytektnes IL-1 U~e~lton, 1985), IL-2 (Herrman $1;
87., 1985) and tumour necrosis facter (Beut1er et 87'1
1986).
The exact sequence of events occuri n9 between bindi ns of IFN-
gamma to its receptor and gene activation is, at present, not
known. However, IFN-gamma has been shown to induce slow rises
in intrace11ular levels of calcium (starting 5-10 minutes after
oinding and being completed by 15-?O minutes) (Somers et
a7., 1986) and to enhance the potential activity of protein
kinase C (PKC) (Figure 11). Additional stimulation of the cells
with a secondary signal (e.g. LPS) results in enhanced
phosphorylation of endogenous protein substrates (Adams &
Hamilton, 1987). How these factors then activate the
interferon-responsive genes remains to be established.
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FIGURE 11. A model for signal transducti6n
following binding of IFN-gamma to
its receptor.
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3.3.1. Effects of IFN-gamma o~ the
Expressioh of Surface Receptors
Many of the molecules expressed on the monocyte surface, after
exposure of the cells to IFN-gamma, have been shown to
demonstrate receptor function (Hoover & Meltzer, 1989). Some of
the receptors expressed incl ude: IL-2 receptors (Herman at
a7., 1985)i high affinity Fe-gamma receptors (Guyre at
a7., 1983); leukocyte function adhesion-1 (LFA-1) molecules
(Weinberg at a7., 1984); and MHC Class II molecules (King &
Jones, 1983). The increased expression of these receptors may
have important consequences for ce11 function:
1) tL-2 may playa role in granuloma formation since
macrophages in a granuloma have been shown to exhibit
receptors for IL-2 (Hancock et a7., 1986).
2) An increased expression of Fe-gamma receptors on
macrophages enhances the ability of the macrophage to
ingest opsonised particles (Guyre at a7" 1983).
3) An enhanced expression of LrA-i molaculos is likely to play
a role in the development of multinucleated gaint cells
sihce this molecule has been shown to mediate monocyte
aggregation (Weinberg at 81., 1984).
4) The increased expression of MHC Class IX molecu1es endows
the macrophage with the ability to present more processed
ant isen to T 1ymphooytes (Rosentha 1 at it 7oJ 1975).
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3.3.1. Effect of IFN-gamma on Production
of Secretory Products by
Macrophages
IFN-gamma has also been shown to induce monocyte production
and secretion of soluble factors (Adams & Hamilton, 1987).
These include: increased TNF secretion (Phillip & Epstein,
1986); increased IL-1 synthesis in response to LPS (Gerrard et
a7., 1987); enhanced prostaglandin release (stevens et
a7., 1989) and the synthesis of dihydroxy vitamin 03 (Rook
et a7., 1986) is increased.
TNr, which is released by activated macrophages in developing
granulomas may act in an autocrine way to enhance its own
synthesis and release. This process would favour further
accumulation of macrophages and an increase 1n the
differentiation of these latter cells into epitheliod cells.
This leads to the formation of a fully developed granuloma
capable of preventing bacterial dissemination and allowing
eTficient bacterial killing (Kindler et a7., 1989).
IL-1 will act, in conjunction with antigen, as an activator of T
lymphocytes (Sisson 8t Oinarello, 1989) and these aut tvated r
cells (both helper and cytotoxic) then play an imol"rtant ,
the killing of M.tubercu7osis (Kaufmann, 1989).
The enhancement of prostoql andtn release may, contrary to the
other cytok ines , act to downregulate the macrophage response to
foreign organisms, thereby terminating an active immune response
(Stevens at a7., 1989).
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The increased production of 1,25~dihydroxy vitamin D has been
shown to enhance the inhibition of growth of M.tubercu7osis
within macrophages (Rook, 1988).
3_4_ THE ROLE OF IFN-GAMMA IN ENHANCING
BACTERICIDAL FUNCTIONS OF
PHAGOCYTES
Activation of the macrophage and PMN cell intracellular
killing ability has been shown to occur 1n the presence of
IFN-gamma (Nathan at a7., 1983). This function of IFN-gamma
has proven to be important in enhanoing the phagocytes capacity
of killing several intracellular pathogens, ~ncluding
Blastomyces dermatitidis (Morrison at al., 1989),
Listeria monocytosenes (Peck, 1989) and mycobacteria (WaH,er
& Lowrie, 1981; Crowle & May, 1981; Rook at 87., 1985).
The presence of IFN-gamma has been shown to result in an
effective enhancement of the oxidative metabolism of both
phagocytic cell types (Peck, 1989; Cassatella at a1., 1988),
resulting in an increased production of toxic reactive oxygen
radicals such as hydrogen peroxide, hydroxyl radicals and
superoxide (Peck, 1989).
Enhancement of phagosome-lysosome fusion by IFN-gamma has been
well documented. Experiments with the intracellular parasite
Sa7mone77a typhimurium, that inhibIts phagosome-lysosome
fusion, demonstrated that IFN-gamma c()u1d effectively reverse
this inhibition (Kagaya et a7., 1989). A similar
enhancement of phagosome-lysosome fusion was shown in
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bone-marrow macrophages infected with ~fycobacterium bovis
(Flesch & Kaufmann, i988). Recombinant IFN-gamma activated
bone-marrow macrophages have been shown to inhibit mycobacterial
growth by 98%. Addition of increasing concentrations of
suramin, an inhibitor of phagosome- lysosome fusion (D'arcy Hart
& Young, 1975), practically reversed this growth inhibition. In
addition, Flesch & Kaufmann (1988) showed that inhibition of
mycobacterial growth was not reversed significantly by oxygen
scavengers. Together these two findings suggest that
enhancement of phagosome-lysosome fusion might be another
mechanism by \'IhichIFN-gamma activates macrophage
antimycobacterial activity.
An inhibition of the intracellular multip1icati0n of
Legione77a pneumophi7a within monocytes treated with
lFN·-gamma has also been documented. In this system lFN-garmla
limited tho availability of iron and dcwn-reau lated transferrin
receptors (Byrd & Horwitz, 1989). L. pneumophi7a has a
definite metabolic requirement for iron and phagocytes acquire
iron via transferrin receptors. By down-regulating tM number
of transferrin receptors on the cell surface, lFN-gamma limits
the amount of iron within the call and thereby limits
L.pneumophi7a multiplication (Byrd & Horwit2'..1989).
Inhibition of intrace'lular growth of both Ch7amydia
os ititec t and Toxoplasma gondii within fibroblasts has been
shown to depend on treatment with IFN-gatnma (Byrne at el .,
1986; Pfefferkorn, 1984). It h:ls been postulated that the
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mechanism by whtch IFN··gamlilaenhances killing in this system
is by the induction of indoleamhe 2,3-dioxygenase which
cata 1'isas the degradation of t rvntophan, IFN-gamma has been
shown to induce irdoleumine 2,3-dioxygenase activity in
monocvtes and macrophaqes , thereby possibly enhancing the host
defences against these organisms (Carlin et a7., 1989).
Anoth~r role of lFN-gamma in augmenting intracellular killing is
its ability to stimulate the release of lysoayme , a potent anti-
bacterial agent, from lysosomes (Lewis at a7., 1990). The
studies carried out by Lewis et aT. (1990) showed that
lPN-gamma, in the presence of suboptimal concentrations of LPS,
stimulated mcnccytes to release greater amounts of lysoavme.
3.5. RO~E OF lFN-GAMMA IN MYCOBACTERIAL
INFECTION
In vie~1 of the abil'ty of IFI\I~'gammato act ivate the various
tntr'ace llujar ki 11 ing mechanisms, a role for IFN-gamma in
activating phagocytes to kill mycobacteria can be envisaged.
Several recent conflicting reports have appeared examining these
effects (Douvo.s et a1., 1985; Rook at a7., 1986a; Flesch
& Kaufmann, 1987).
Douvus et a7. (1985) showed the IFN-gamma pretreated
macrophages became tumoul'icidal and leishmanicidal but that
there was an enhanced replication of mycobacteria in thesl~
macrccnases. Other groups (Walksl' & LO\~I'ie, 1981 i Rook et:
a 7., 1985) have shown that mlll"ina peritonea1 macroohases can
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be activated by unpurified T cell products, which may contain
IFN-gamma. This result~d in the intracellular destruotion of
M.microti (Walker & Lowrie, 1961) or the ihibitit10n of
M.tubercu7osis multiplication within macrophages (Rook at
et «, 1985). Rook et et, (1986) have also shown that
IFN-gamma has variable effects on mycobacterial growth in human
monocytes. These vary from enhancement of growth of
mycobacteria (Douvas et a7., 1986) to significant inhibition
of growth of the orsantsns (Flesch s Kaufmann, 1987). This
differed from the effect of IFN-gammD on mouse peritoneal
macrophages where consistant inhibition of growth was seen (Rook
at a7., 1986a). Such discrepancies m~y be due to the fact
that there are distinct subpopulations of macrophug9s at
different stages of maturation in the human system (Rook et
a 7., 1986a). Flesch & Kaufmatm have done an axtanstve amount
of \~orl<with the anti-mycobacterial function of murine bone
marrow-derived rnacrophages. TMir data shows that:-
(1) when treated with IFN-gamma, the macrcpheses have
increased anti-mycobaoterial activity (1987);
(ii) different strains of M. tuberculosis have different
suscept ih i1it. y to IFN-gamma act ivatsd macrophaqes (1987) i
(iii) 'inhibition of M.bovis by IFN-gamma act tvaced
macroohases is an oxvsen-fndependent; precess stnce the
inhibition was not reversed b~ scavengers of reactive
oxygen metabolites (1988);
(iv) enhancement of ohasoscme- ysoso!l1ef'us ion to due to
!FN-gamma treatment might resu1t in th1s increased
inhibition of mycobacterial growth (1988).
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3.6. CONCLUSION
The exact role played by I~N-gamma in tuberculosis is
therefore still uncertain. This uncertainty is underscored by
two recant review articles by Kaufmann (1989) and Rook (1990)
which emphasise the opposing roles of IFN-gamma. Kaufmann
(1989) has suggested that IFN-gamma plays an important role in
protection against the tuberclo bacillus, whi1st Rook (1990) has
sllggested that IFN-gamma has only a partiel restorative effect
in humans and may in fact playa more important role in the
immunopathology of tuberculosis rather than in immunity to the
disease.
82.
CHAPTE:R 4
MATGRXALS AND METHOOS
83.
4.1 . PREPARATION Or MYCOBACTeRIUM
TUBeRCULOSIS ORGANISMS
Bacterial Isolation and Preparation4.1.1.
M.tubercu7osis organisms from human sputum specimens were
grown on Lowenstein-Jensen slopes for 2-3 weeks at 370C.
Colonies were scraped off into physiological saline and the
suspension was centrifuged at 200g for 5 minutes to remove any
of the Lowf.)n~tein-Jensen medium that may have contaminated the
bacterial suspension during the iso1ation procedure. The
supernatant was collected and centrifuged at 800g for 30 minutes
at 40C, followed by 2 successive washings of tha pal let in
saline. The mycobacterial suspension was homogenisod with a
homogeniser using an 18K probe (Janke & KunKel KG, Staufen,
Breisgau). The mycobacteria were thGn autoclaved and sonicated
in an MSE Soniprep 150 sonicator (18um peak to peak). All
homogenisction and sonication was carried out at 4°C. The
sonicated material was centrifuged at 800g far 15 minutes, the
supernatant carefully collected, and the prote~n concentration
of the sonicate determined using the B10rad protein Gstima.tion
;dt (Biorad Laboratories, Richmond, California, USA) uccording
to the manufacturers instructions. The mycobacterial sonicate
was aliquoted and tltored at concentrations of 1mg/m1 at -2000
unt 11 requ ired.
Fractionatian Qr H. tuberculosis
extracts ~y Gel Filtration
Chromatography
Sonicated M.tu~ercu7osi$ extract was passed through a
4.1. 2.
sephacry1 $-200 co1umn to separate various fractions according
to size.
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4.1.2.1. Preparation of Sephacryl S-200
Column
sephacrv! 8-2QO (Pharm8cia Fine Chemicals, Uppsal a, Sweden) was
packed in a 940 x 150mm Pharmacia column by gravity. This
column was equi1ibrated with PBS (pH 7.4) (appendix I) at a flow
rate of 0.5ml/minute for a fUrther 2 days at 4°C. Even
packing of the column ~/as confirmed by observing the passage of
Dextran blue T2000 (Pharmacia, Uppsala, Sweden) through the
column. The vOld volume of the column, as determined by Dextran
blue exclusion, WD. found to be 60ml.
4.1.2.2. standardisation of Columns
co lumns \~ere standardised by using proteins of known mo'lecular
weight. These included: ribonuclease (14kDa), 'wmotrypsitl
(25kOa), carbonic anhydrase (30I<Da), bovine serum albumin
(67kOa), alcohol dehydrogenase (1501<0a); aldolase (1581<0a) and
catalase (232kOa) (all from Pharmacia Fine Chemicals, Uppsala,
Sw~den). The proteins were dissolved in PBS to a final
concentration of 5mg/1111. Two milli1itres of each protein
solution were layered onto the column and the fractions
co llected in 1m1 volumes in a spectra/chrom fraction eel lector
(Spectrum Medical Industries, Los Angeles, USA). Fraction
collection was initiated when half the protein solution was
judged to have entered the column. The elution volume of
various standards were determined and a standard curve drawn
therefrom.
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4.1.2.3. Fractionation of M. tuberculosis
sonicates on Sephacryl 9-200
Columns
To fractionate M.tubercu7osis antigens, 2m1 of mYcobacterial
extract at a concentration of 1mg/ml was loaded onto the
column. One millilitre fractions eluting from the column were
collected and protein elution profiles of the fractions were
assessed. By comparison with elution profiles of the known
standards, eight major protein peaks (arbitrarily defined <.nd
alphabetically termed A - J) of molecular size ranging from 669
to 14 kilodaltons (I<Oa) were obtained.
4.1. 3. concentration of H.tuberculosis
Fractions
The major protein peaks obtained from the column have previously
been assessed for their ability to 1nhibit the intracellular
killing capacity of phagocytes (Wadee at 87., 1987). To
confirm these results, and to determine more precisely its mode of
action, the effect of the 25kDa fraction on other phagocyte
functions was investigated. The aliquots in pe1k H (elution
volume 106..125m1) corresponding to proteins of a molecular weight
of 25kDB, were pooled, poured into spectrapor d1alysit tubing
(S~ectrum Medical Industries Inc, USA - molecular weight cut off
point $-8 000 daltons) and concentrated by placing the dialysis
tubing in Acquac tde II (Calbiochem corp. I La Jolla, USA) at 40C.
Protein estimation was done on the concentrated fraction using the
Eliorad protein assay. A standard curve was plotted by ill' "'1n9
the absorbance values of known concentrations of BSA (ranging frail'!
2-200mg/ml). The concantrated fraction at 1mg/ml was then
a1iquoted and stored at -7000.
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4.2. ESTABLISHMENT OF MONOCYTE
MONO LAYERS
Venous blood was collected into preservative free heparin
(10units/ml - Sigma, St Louis, MD, USA), separated by
centrifugation on hypaque-ficoll gradients and the mononuclear
ce11 fraction at the p1asma-f ico 11 interphase co11ected. The
cells were washed 3 times in physiological saline and
resuspended in RPMI-1640 (Highveld Biologicals, JohannesQurg)
containing 10% fresh autologous human 3erum. Mononuclear cells
at a concentration C't J x 106/m' ware then plated in ltl ,I
wells of lab-Tech tissue culture chamber/slides (Miles
Scientific, Naperville, Illinois, USA) each wall containing
O.5ml.
Cell cultures were incubated for 60 minutes at 370C illa
humidified incubator containing 5% C02 and 95% air. At the
end of this cul~ure period non-adherent cells were removed by
yJashing 3 times with warm (3700) sal ine. The remaining
adnerent cells were then cultured il)RPMI-1640 containing 10%
fresh autologous serum and 100 units of penicillin and
streptomycin. Cultures wers maintained by removing half of the
supernatant fluid and replenishing with an equivalent amount of
RPMI-1640 medium containing serum e'y')ry4 days. Growth of cel1s
was examined using an nverted microscope and wells were
expanded \~hen the monolayer had reached 75% confluency.
Expansion of cells was performed by vigorous pipetting of cell
cultures followed by plating into equivalent w.ells wit!) an 8!lual
volume of medium containing 10% fresh autologous serum, Cell
viability waS assessed by crypan blUe exclusion and col1
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cultures were maintained for 2 months or longer. To ascertain
th~ purity of the macrophage cultures, the cells Were incubated
with the monoclonal antibody OKM1 (Ortho Diagnostic systems
Inc., Raritan, NJ, USA), stained with the esterase stain and
assessed for their phagocytic ability,
4.2.1. Assessment of Macrophage Purity
4.2.1.1. Assessment oT OKMl uinding by
Macrophages in Culture
Macrophages grown in tissue chamber slides were fixed onto
s 1ides by add'ing methanol into the chamber and incubat 1ns at
room temperature for 1 minute. The slides were washed and 200ul
of the monoclonal antibody OKM1 (Ortho Diagnostic Systems Inc.,
Raritan, NJ, USA - 1:50 dilution) were added to each chamber and
the slides incubated at room temperature for 2 hours, after
which they were washed 3 times in PBS. Fluorescein
isothiocyanate labelled rabbit anti-mouse antibody (Boehringer
MannheiM, Frankfurt, Germany - 1:50 dilution) was added to each
chamber and the slides incubated for 60 minutes in the dark.
The unbound conjugated antibody was WiG had off with 3 washa~ in
PBS and the slides viewed under a fluorescent mtcroscoc '.
4.2.1.2. Assessment of Esterase Activity of
Adherent Cells
Esterase activity was assessed by the naphthyl acetate method
(Davis & ornstein, 1959). A solution of pararosanilin was Made
by adding 29 of pararosani1in hydrochloride (Chroma, Stuttgart,
Germany) to 5ml of 2M hydrochloric acid (Merck, Darmstadt,
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Germany). This solution was fi1tered and stored at 40C
until used. Sodium nitrite solution was made by adding 400mg of
sodium nitrite (Analar-BOH, Poole, UK) to 10ml distilled water.
This solution was stored at 4°C for no longer than 2 days.
Tha incubation mixture for the esterase staining was prepared
freshly each time by adding O.4ml of pararosanilin solution to
0.4ml of sodium nitrite solution. The reagents were allowed to
react for 1 minute to form hexazot izad pararosant ltn (HPR) which
was then added to 7.25ml of phosphate buffer so1ution (2.75%
NaH2P04H20). Two hundred and fifty microlitres of freshly
made alpha-naphthylacetate (1% in acetone) was added to the
incubation medium. The pH ves adjusted to 7.4, after which
2.5ml of distilled water was added to the mixture.
Cel IS were fixed on slides in 2% glutaraldehyde (BOH Chemicals
Ltd., pool~, UK - diluted in PBS) for 10 minutes. The slides
were then washed in water for 20 minutes and the water changej
10 times in the course of the washing procedure. Slides were
stained for 60 minutes at 37°C using the incubation mixture
for esterase staining, followed by washing for 10 minutes under
running water and then dehydrated using increasing
con~Jnt~a~1ons of a1cohol (50%, 70%, 90%, 96% and 100%),
immersed in xylene and mounted with Depex (Gurr, aOH Chemicals
Ltd., Poole, UK). The number of esterase positive cells were
enumerated under oil immersion (xiOO lens) and expressed as a
percentage of 200 adherent cells counted.
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4.2.1.3. Phagocytic Properties of Adherent
cells
Bakers' yeast prepared as described in Section 4.4 were used.
To adherent cells, grown on chamber slides, 0.1101 fresh human
AB serum and 0.1101 Bakers' yeast (6 x 106/m1) wer~ added.
The chamrer slides were then placed on a shaker and incubated
at 370C for 30 minutes. At the end of the incubation period
tne sl ides wars fixed in mathano l (BDH Chemicals Ltd., Poole,
UK) for 5 minutes, washed in water and stained with ~ 1:10
dilution of Giemsa (nurr Ltd., London, UK) in physiological
saline for 5 minutes. Slides were dried and 200 cells counted
under oil immersion lens. The number of cells that had
phagocytosed Bakers' yeast were expressed as a percentage of
the total number of cells.
4.2.1.4, Preparation of Adhe~ent Monocytes
for studies of Bactericidal Ability
For bactericidal studies, assessment cd Iysosyme product ton,
H20~ production and glycolysis,' where large numbers of
adherent cells are needed, adherent cells were cultured on
plastic t tssue culture plates (145/20mm - Greiner
t.abor+tschn 11<, Solingen). Twentv mill 11itrss of mcnonuc 1er
cel1s at a concentration of 3 x 106/101 were added to each
plate and the plates incubated in a humidified incubator at
370C overnight.
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Further preparation of the adherent cell cultures was described
for the cells isolated on culture slides (Section 4,2.).
(;u;t"t'edmon=cytes were removed by treatment ti;th iC'Yf)sin-EDTA.
The monolayer was washed with warm (370C) physiolog'i(.;ul
saline and 15ml of a mixture of Trypsin-EDTA containing 0.125%
Trypsin, 0.05% EDTA in phosphate buffered saline (Highveld
Biologicals, Johannesburg) was added to the monolayors and the
cultures incubated for a further 15 minutes at 370C. Cells
were collected, pooled and washed 3 times with cold RPMI
containing 10% heat inactivated foetal calf serum (Highveld
Biolcgicals, Johann They were then counted
and reconst ituted in I "a" ; D, .,;.t' 1 X i07/m 1.
ISOLATlot~ OF PLJL~ . .10NLlCLEAR
LEUKOCYTES (PMN CEL~S)
PMN cel Is were obta tned from normal volunteers following
4.3.
centr!fugat~vn of heparinised peripheral blood o~ hypaque-ficol1
dsns 'tv gradients. The cell pellets obtained were resuspended
in 38ml of physiological st'ine and mixed with 12ml of 3%
gel&tin (Difco, D6troit, MI) in saline. Tho ce11-gelatin
suspension was incubated &t 370C for 30-60 minutes and the
leukocyte rich sL.pernatant removed, cet1trifuged and washed twice
in saline. Residual erythrocytes were lysed with 0.83% ammonium
cn10ride (Appendix 2) at 4°C for 10 minutes. The remaining
PMN cel;s were then centrifuged at 100g! washed, resuspended in
saline and brought to a concentration of 10 x 106/ml in PBS.
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Assessment of Purity of the PMN
Cell Suspensions
To ascertain the purity of tho PMNcell preparations, the cell
suspens iens were counted in Turks' "~hite co11 count in9 f1 ui d and
'in H sysmex 1('1\,')0 (~li1sh, ,Japan) cal l courrtar, Evidenco of PMN
coll purity was assessed by adalng SOul of call suspension to
450ul of rurka' white cell counting fluid and the cerceneaso PMN
eal ls ascertntned microscopically. Tho cell suspensions were
aho assossed by d1ffenmtinl count in tho svsnex Ki0DQ cal l
counter.
4.4. PREPARATION OF SACCHAROMYCeS
C'1:'fU'VISIAft (BAKI!R'S Yl~A~n)
Comm(m~ially avaf l ab le Ball,OfG' yoast was propared by suspending a
small pellet in physiological salino, wushing 3 times by
contrifuging BOml suspensions at 4009 and reBu$pandin~ in oaline
ouch tim~, Tho yeast werE! killed by hoating ai. aovc for 60
minutoD. Tho organisms ware thon washod with saline, rosuspendod
t J (I (,t1Ilcontr'ut'l on of (\ x i0'/mi in sal ino arid storad nt
fU:Jhm, veasts wore washod but not heat ki11od.
4"~>. PIHPfll\tATlClN OF STMW'tl,OCOCCUB
I·WRFUS· (S. IHlIU:US) OIHiAN ISMf;
Col0Yli(l!' of 8tnp/ly7o(;o(;C'u,ca (lun)(1I) Cowun Strain A
(S.d1JrlIUS) ol'ganisll1s wore lnnocul(\t~)d into !lQm1of Mul1er-
lIi1ton modium I.meJ alloWO(i to srml for 3-4 houri) at ~('OC. The
()t'(j{!n1UI7Ifl Wtll'O U1()11 wachod by 3 eontrifU!Jut~(jnG at 400t) 11,
phYGiolofjlou1 sa .tno, Tho s.nureus t),'!)nn1cmu \~(iI'O then
t'Obll.sPOJiliod in PBS to a +'1nn' ccncent.rat ion \1,,1 1 X 1On1m1.
4.6. PHAsnCYTIC ABILITY OF PHAGOCYTES
When th~J phagocyte comes into contact with an invading micro-
organism it wi 11 engulf tl19 organiom and form a phagosome around
it (Werb, 1987). Initial experiments ware therefore designed to
evaluate the effect of the the 25kOa mycobacterial fraction on
the phagocytic ability of PMN cells and culturod monocytes.
Concentrations of culturod il1onocytes or PMNcel", were adjusted
to 1 x 107/011 and 0.3ml of this suspension was incubated with
0.1011 of Bakers' yeast suspension, O.1ml of human AS serum and
O.1ml of the 25kDa fraction (BOus/ml - fina1 concentration) in
5101tubes. The non-phagocytic control consisted of O.1ml of
Bakers' yeast suspension, O.1ml of serum and O.3ml of PBS.
Cultures W\'lro incubated at 310C on a rotating wheel for 50
minutes and 0.2m1 aliquots wer'e removed svery 10 minutes and
added to 0.5m1 of Turks 1eukocyte counting fluid. Phagocytosis
W,\t; expressed as th~ percentage of yeast which had been
1flg6sted. This was calculated by counting the number of
extroce'l1ultu' yeast. particles on a Neubauer heamocytometer and
using thfJ formula:
NO. or extracol1uar organisms
% phagocytosir, : 100' "" ~ ,-,--"- ... -,~~;------. x 100
NO. of organisms in non-phagocytic control
4.7. BACTERICIDA~ ABILITY OF PHAGOCYTES
To assess the bEv..teri ~ida 1 abt 11ty of pha90cyt~s 1 stapnylocl1ccus
organisms wore tncubated with monocytea or PMNcal Ia for' Q
per ted of time aft.er which t~ . number of orsantens not ki1 'led
was assessed by cutturtns supernatants f'rom lysed co11e on blOOd
8gar'. using u modified technique of Quia at a7. (1967),
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Each test system contained O,5ml of 10 x 106/ml PMN cells or
macrcphasas ; a.1m1 of S. eureus and O.1ml fresh autologous
serum. To assess the effect of tho 25kOa fraction on the
bactericida1 ability of phugocytes, O.1ml of different
concentrations of the 25kOa fraction (10,50,100mg/ml) Vias added
to (:lachculture system.
One hundred microlitres of IFN-gamma (r!F'N~9amma ~ Amersham
tnternat tonal , Buckinghamshi rei UK) at different concentrnt tons
(5Q,100,200mg/ml) were added together with 100ul of the 25kDa
mycobacterial fraction to some test systems. In add'ition, a
can free control system contained O.1ml serumj (I.1m1 of
S.8ureus and Q,3ml pas. The final volume in ~11 culture
systems was brousht, to 1m'l with sterile PBS. Oult~;rM were
incubated at 3700 for' 90 minutes c a rotating wheel. At the
end of this period, O.1ml a1iquots from each system were added
to a.aml sterile distilled water and then sorially diluted in
distilled water to a dilution of 1 x 10-4 and 1 x 10-s• Of
those dilution:., 0.1011 was plated out on blood agar plates and
tho plates incubated overnight at 3700, after which the
colonies were counted. The difference in counts botwoon the
test and contro1 systems were assessed after approximately 18
heurs and the percentage of bacteria ki11ed intracel1ularly was
determined using the formula:
No. of celonies in tast $YSto~
No, of colonies in cell-tree control sY3tem
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4.8. PHAGOSOME-LYSOSOME FUSION
Whon microorganisms are ingested by phagocytes, they are
enclosed within phagasomes (Werb, 1987). !.ysosomes present in
the cytoplasm of the phagocyte are capab1e of fusing with and
di schargi rig thei r contents into the pl1agosomo such that the
foreign particles within the phagosome are degrl:l.ded (Armstrong &
D'Arcy Hart, 1971). To assess the procoss of phagosome~'ysosome
fusion u'Arcv Hart & Young (1971) described a technique \1nereby
phagocytes are incubated with acridine orange, a lysomotropic
fl uoresent dye I whi ch \'iill be transferred to the phagosome 1f
fus 1on of the 1ysosome and phagosomo occurs. Phagocytosed yeast
cart+ctos will then fluoresce green if they are killed,
indicating successful phagosome-lysoeome fusion.
~lonocytf.lS or freshly prepared PMNcells at 1 x 1Oo/ml ware
used to a~sess the effect of the 25kDa on phagosome-lysosome
fus ton, Monocytes grown in culture on 8 chamber t.ab-rak slides
were pralabs l led with acr'idtne orange (Merck, Darmstadt,
Gor'many). Two hundred mi11i1itres of the acrid'if1e orange
onlut ion (tl\J9/m1i) were added to each chamber. Ou1turss wore
then incubated for 15 minutes at 370C, aftet' which tho
acridine orangs vas poured off, fresh RPNI (ml11ntained at
37(0) addod to each chamber ar.=! the cE)11s incubated for a
further 15 minutes at 3100 to a"m~ for the dye t~ concentrate
in the lyaosonea, The cells were then washed 3 times Wi ~.hwarm
(3700) medium and used in assays to visualise phaoosame-
ly~osome fusion.
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To label PMNcells, acridine orange (5ug/ml) was added to 2m1 of
a PMNcell suspension, and the tube 1ncubatp~ 'Toe for 15
minutes. cons wer(l then centrifuged at 2009, resuspended in
RP~tI (maintained at 370C) and incubated for a further 15
minutes at 31°C.
Acridine orange labelled phagocytes were incubated with
opsonised y~ast (100u1) (Appendix 3) for 30 minutes at 310C,
after which the cells were extensively washed with warm PBS to
remove non-phagocytosed yeast cells. Fusion was allowed to
progress for a further 30 minutes at 31°C.
In experiments in which the ~ffects of the mycobacterial
fraction on the fusion process were examined, 100ul of the
fraction at a final concentration of 50 or 100ug!ml were added
to the ce , I:.... !n some tAst systems, IFN~galYlma(50, tno , 200,
50QU/m1) was added with the 25kOa f'ractiton (60ug/1ll1) or alone
(cant ro 1) • T' :1na 1 v« 1ume of each system was m~\inttl ined at
400u1. After the 'last 30 minute incubation period t~'IGplastic
chambers of the mac~ophage cultures wore removEld f ' the slides
and wet mounts were made and examined upder a UV microscope.
For' the PMNcells, drops of the coll suspension were p1aced onto
slidss and exemtned under a UVmicroscope (Leitz, Westlar,
Germany). Using the criteria of Goren at aI. (1984), yeasts
were regarded as having been Id l led when they apPElarad uniformly
bright groan; cells in which fluorescence was restricted to tho
periphery of the yeast part tc le were placed in thl~ intermediate
category, implying an early stage of phagosome-lysosome fusion
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and yeasts that .opeared non-fl uorescent were regarded as not
having acqu t t'(:J(j acr tdtne orange by phagosome-lysosome fusion.
This indicated that fusion had bee II delayed or was inhibited.
Viability, non-viability and intermediate killing of yeast cells
were scored independently by two inveDtigators.
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4.9.1.
LYSOSYME PROOUCTION ANO ASSAY
Lysosyme Production
Lysosyme is a cationic enzyme, present in both macrophages and
PMN cells, which has the ability to hydrolys~ N-acatyl muramic
P-1, 4 N-acetyl glucosam1ne linkages in bacterial cell walls
(Gordon et a 7. I 19'(4). It may therefore have an important
rola to play in the mycobactericidal abil~ty of phagocytes.
Since the 25kDa fraction has been showr to inhibit intracellular
Id 11ins by phagocytes, it was of interest to examt ne the affects
on the production of Iyaosyme,
Macrophages grown on 145mi'llti'su~ cutture plates for 6 weeks or
longer' were removed by TrYPslil-EOTA triaatl'llOnt (Section 4.2.4.).
The ce 11s were resuspended in RPM! to a concentrat ion of
10 x 101l/m1. PMNcells, isolated as describel;! in Section
4.3., wei's also reconstituted ; n PBS to a concentration of
10 x 106/1'11'1.
The production and release of lysDsyme was initiated by
incubatin9 11'111of cell suspension (either macrophagas or j.)MN's)
with 200u1 of yeast particles at a concentrat+on of GOx 101)/011
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in the presence of 200ul of fresh human serum and 100ul of
varying concentrations of the 25kDa fraction, IFN-gamma or RPM!
The tubes were Incubated for varying periods of time (10,15,30
and 60 minutes), after which they were centrifuged at 3009 for 5
minutes and the sU;3rnatant collected was stored at -200C until
used.
4.9.2. Assay of Lysosyme Production
Lysosyme production was assayed by the method of Gordon at
87. (1974) by measuring the initial rate of lysis of a
suspension of Micrococcus 7ysodeikt1cus (M3770, Sigma, St
Louis, MD, USA) with the aid of a PYE Unicam flU 8800
spectrophotometer f'ltted with an automatic reader. standards
of lvsosvms (Siekagaku Kogyo Co. Ltd, Tokyo) t'ich materials
wel'a diluted in PBS. Reaction conditions were as follows: 1ml
of sample was mixed at room temperature with 2m1 of a
suspension of M. 7ysodeikticus at a concentration of
O.25ms/ml tn ).067M phosphate buffer, pH 6.3. The rate of
decrease in turbidity was measured at 540nm, w:th a ratio
switch position of 0.5 and with a full recording scale ecual to
0.3 oPtical density units. The initial reaction was linear for
at least 1 minute and was directly proportional to as.; lysosyme
concontrations in the range 0.2 to 2us/ml.
98.
4.10. ASSESSMENT OF NITROBLUE TETRAZOLIUM
REDUCTIOI~
4.10.1. Introduction
stimulation of phagocytes (either by an agonist or by
phagocytosis) results in a marked incrf:!aseof the oxygen
consumed by these calls (respiratory burst) (Sawyer at 87.,
1989; Bab1or, 1978a). This increase of oxygen consumption
results from the activation of an NADPH oxidase which reduces
oxysen to a superox 1de rad ica 1 (02 -) (Psact ion 1, page 100).
Assoc tated with the respiratory burst is tha activation of the
hexose monophosphate shunt, a high energy yielding metabolic
pathway which generates the NADPH used by the cells to t~oduce
luperoxide (Pick, 1985) (Reaction 2, page 100).
iNitroblue tetrazolium (NBT) acts as a non..specific electron
acceptor in this series of react10ns, such that the yellow dye
becomes reduced to an insoluble blue forll1azan(Hudson & Hay,
1980). These insoluble granules can then be seen in the
cytoplacm of the cell (Hudson & Hay, 1980). Production of
reactive oxygen radicals by Phagocytes is reflected by
enum~rating the percentage of cells demonstrating redUced
tetrazolium within their cytoplasm (Baehner et 81., 1976).
4.10.2. NBT Assay Procedure
Cells present in buffy coats obtained by sedimentation of
hepar tntsed whb1e b100d were used in the NBi assay. Oel1
systems comprised 200ul of buffy coat derived cells incubated
with 200ul of endotox in activated serum (EAS) (Appendix 4) in
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the presence of the 25kDa fraction (100ul); 10oU/ml of !FN-gamma
(100ul) or both. Unstimulated cells (control) were incubated
with 200ul human serum (not EAS) and 200ul of PBS.
After an incubation period of 30 minutes at 370C, 400ul of NBT
(Sigma Chemical Co, st Louis, MO, USA) solution (Appendix 5) was
added to each tube and the cell suspension allowed to incubate
for 15 minutes at 370C, followed by a further 15 minutes at
room temperature. Smears of each samp1e were then made, allowed
to air dry, fixed in methanol for 1 minute and stained with well
filtered haematoxylin for 3 minutes (Appendix 6). Tho slides
were washed well under running water, allowed to dry and the
smears examined under oil immersion. Cells with a large bluish
preCipitate were regarded as having reduced NST.
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4.11.1
HYDROGEN PEROXIDE PPODUCTION
Introduct~on
By qpontaneous dismutation, the Oa- produced by the
oxidation of NADPH, reacts with the hydrogen prot~11S to
produce H20! (Pick, 1985). The rate of this reaction can,
however be increased 10 fold by the action of superoxide
dismutas9, present within phagocytes (Pick, 1985). Hydrogan
peroxide (H202) is another bactericida1 agent used by
phagocytes to destroy invading microorganisms (McRipley &
sharra, 19oi).
(Reaction 1)
(Reaction 2)
',IADPH+ 02
100.
------~ 02- + NADP+ + H+
NADPH oxidase
Glucose-6-phosphate NADP+
6-phosphogluconate NADPH
10·[ •
4.11.2. Measurement of Hzoz Production
To measure the n202 produced by monocytes and PMN cells a
microtechniqu9 using 96-well flat-bottomed microtitre plates
(sterilin Ltd., Middlesex, UK), essentially as described by Pacon
& Ferrante (1983) was used. To each well 70ul PMN cells or
monocytes (which were prepared as described in Section 4.2.1. and
4.3, respectively); 20ul horseradish peroxidase (250ug/ml type IV
- Sigma Chemical Co, St Louis, MO, USA); 70ul phenol red
(500Ug/ml - Merck, Germany) (Appendix 7) and 40ul opsonised yeast
(Appendix 5) was added. All solutions were made up in PBS. Test
or contol systems contained 20ul of the 26kDa mycobacterial
fraction, or PBS respectively. The 25kDa fraction was used at
V8l'y;ng concentrations ranging from 10ug/ml to 100ug/ml. In some
·experiments, IFN-gamma was included in the culture system whereby
20ul of IFN-gamma were added at a concentration of 200U/ml. The
plotes were incubated at 370C for 60 minutas after which the
reaction was stopped by adding 25ul of 2M NaOH. The absorbance
at 62;1nM was measured in a Titertek Mult.iscan Me spectrophoto-
meter (Flow Latoratorien, 8i09910, Switzerland). Th~ assay was
standardised with freshly diluted H20:? (SDH chemi ca'ls Ltd,
Poole, UK) and was linear over the range 0 - 60uM.
4.12. HEXOSE MONOPHOSPHATE SHUNT (HMPS)
ACTIVlry
4.12.1. Introduction
On activation, phasocytes ch€.r.gethei r metabol ic orocassas from
a low energy yielding, oxygen independent glycolytic pathway +,0
the aerobic, high energy yielding HMPS (Babior, 1918a).
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The pathway orovtdes a mechant=s for sp l ittil1g the carbon
chain of a glucose molecule one carbon at a t lme , releellsing
C02 and energy and regenerating NADPH which Dcts as an
electron dC'i1or for NADPH oxidase (Babior, i918a).
4.12.2. Assessment of HMPS Activity
HMPS activity vi"". assessed by the production of 14C02 from
glucose-1-!4C (Ne11 England Nuclear, Boston, MA, USA) by the
method of Wc"',d et 87. (1963). ce 11s were suspended to a
final concentration of 2 x 107/m1 in O.15M g1ucose~free PBS.
The test apparatus was a 'IOm1 glass scintillation vial (Packard
Instruments, III tnof s USA) which served as the (Juter chambar-,
stoppered with a tightly fitting perforated mete" lid. Inside
this chamber was placed a 1.0m1 autoanalyser cup whi~h served as
the inner chamber , The react ton "1xture consisted of: 100ul
glucose-1-1~C co.07uei); 100ul Bakers' yeast (£0 x 106/m1);
100ul fresh serum: 100ul 25kDa mycouacterial fraction (50Ug/ml);
100ul IFN-gamma (200U/ml). Appropri ate vol urnes of PbS Wc\S added
to control cultures which did not ccntat- the 25kDa fract,iorl Or'
IFN~gGlmma. This reaction mixture was placed in the outer-
chamber and 600ul of a solution of 1M KOH (Merck, Darmstadt,
Germany) was placed in the inner chamber (autoanalY~l:lr cup).
The tnner chamber was can~fvlly lowered into th~ scintillation
vial and allowed to stand at 3100 for 10 minutee. 1'he
reaction was initiated by introducing 200ul of cell euspenstcn
(prepared as described in Section 4.2.4. and 4.3) into the outer
chamber by injection throllgh the rubber' lined cap '!lith a syringa
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to which a long-needle was attached. The reaction was
terminated by the additon of 2ml of 2M He1 after 60 minutes.
The chambers were allowed to stand at room temperature for a
further 60 minutes to permit the release of 14C labGl1ed CO~
and its subsequent absorption by the KOH. Aliquots of 500ul of
the inner chamber mixture were then transferred to sctnt t l1ation
vialG containing 10ml of acidified instagel (Appendix 8)
(Packard) and counted in a LKB liquid scinti1lation spectrometer
(Stockholm, Sweden) for 10 minutes each.
controls consisted of the reaction mixture deVoid of the cell
suspension, and the counts so obtained (background counts) were
subtracted from the corresponding experimental values. All
tests were performed in duplicate and expressed as corrected
(minus background) counts per minute (c.p.m.).
4.13. M~ASUREMENT OF THE GlYCOLYTrc
PATHWAY
4.13.1. Introduction
Glycolysis ;s a pathway used by calls to supply energy required
for normal cell functioning. This pathway involves the
conversion of g;ucose via a series of reactions to pyruvate
which is then reduced to lactate by lactate dehydrogenase
(Metzler, 1977). The extent of glycolysis by both resting and
stimulated cells was measured by lactate production (Hohorst,
19(2), using recognised procedures (Boehringer- Mannheim
btochemtcal test combination).
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4.13.2. Method
4.13,2.1, Production of Lactate
This assay was performed in two parts. In the first, lactate rich
supernatants were produced and in the second aliquots of these
supernatants were assessed for the amount of lactic acid
produced. Monocytes maintained in culture were removed front the
plastic tissue culture plates as described in Section 4.2.1. and
PMN cells were isolated as described in Section 4.3. Both cell
types were r~suspended in 0.15M PBS containing 10mM glucose (BDH,
Poole, UK). Each assaY was performed in duplicate. The reaction
mixture consisted of: aOoul cells (1 x 107/ml); 200ul serum
(control) or EAS (25%) i 100ul 25kDa mycobacterial fraction; 10aul
IFN-gamma (200U/ml). PBS was added as required to each tube to
make up the final volume to SOOul. Tubes were incubated at 370C
for varying periods of time (10, 20 and 30 minutes) and the
reaction was stopped by deproteinisation with the addition of 1ml
of cold O.6N perchlor ic acid (PCA). rhe tubes were mixed we 11 ,
vortexed and centrifuged at 400g for 10 minutes. Supernatants
were collected and used to maaaure the lactic acid produced.
4.13.2.2, Assessment of Lactate Produced
Aliquots of supernatants from each tube were assay~d for lactic
acid by monitoring the spectropllotOh'letricchange accompanying
the reduction of the enzym~ cofactor ~ nicotinamide adenine
dinucleotide (NAD+) to NADH during the conversion of laGtate to
pyruvate by 1actate dehydrogenase (I.DH)'
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Lactate
LDH
Each tube contained the following: 2101 assay buffer (Appendix 9);
200ul 27mM NAD; 20ul LDH (2m9/m1) diluted in 2.1M NH4S04:
200ul supernatant fluid. Control tubas cuntained 0.6N peA instead
of supernatant fluid. The tubes were incubated at 250C for 60
minutes and the change in optical density at 340nm (AE 340nm) was
assessed spectrophotomatrical1y using a PYE UN!CAM PU8BOO
spectrophotometer (Phillips Analytical). Resu1ts were expressed
as ug lactate/6 x 106/ml/unit time by the conversion fuctor
1.25 x 6E 340 x 1 000 as desert bed by Hohorst (1962).
4.14. ANTIGEN PRESENTATION BY MACRO PH AGES
TREATED W~TH THE 25kDa
MYCOBACTE~IAL rRACTION
lntrodut:tion4. 14 . 1
Provious studies (Wadel et 87., 1987) and tho presont work
demonstrate that the 25kDa mycobacterial fraction inhibited the
intracellular killing ability of the macrophage. In addition,
these studies have also shown its effects on the intracellular
degr'adative functions of the macrophage. It was of interest,
therefore, to determine whether the 25kDa mycobacterial fraction
had any effect on the antigen presenting capacity of the
macrophage. This was assessed by lymphocyte proliferation
assays to both mitogens and antigens.
'oj.
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4.14.2. Method
Mononuclear ce1 is from PPO positive donors, separated on
Hypaque-F;coll density gradients, were plated onto 96-well
flat-bottomed microtitre plates (Starilin Ltd., Middlesex, UK)
at a concentration of 1 x 106/ml (200ul/well). The non-
adherent ce11s were removed by washing 3 times with warm
(370C) medium. The adherent cells were then treated with the
25kOa fraction at a fin.il concentration of 50ug/ml his
concentration was used as it optimally inhibited the var tous
pathways of phagocyte function) for 60 minutes, followed by
washing 3 times with warm mediLim to remove the 25kOa
mycobacterial frnction.
The non-ache rent ee 11s removed from the 96-we 11 plates we re
re-adhered for one hour on plastic tissue culture plates
(145/20mm - Greiner Labortechni~, Solingen) in order to remove
any remaining adherent cellS. The non-adherent cells were then
collected, washed and resuspended in RPM! 1640 containing 10%
autologous serum to a concentration of 1 x iOa/ml, so as to
reconstitute a ratio of 20:80 (macrophagss to lymphocytes), Two
hundred microlitres of this cell suspension was than added to
eaCh well containing macrophages treated with the mYCobacterial
f'ractrlon, TI~e lymphocytes were then stimulated with purified
protein derivative (prD) (Connaught Medical Research
Laboratories, Canada) at a final concentration of 1, 5 and
10ug/mlj phytohaemagglutinin (PHA) (Wellcome Laboratories,);
Concanav1l1n A (con A) (Pharmacia, uppsala, Swadan) or pokeweed
mitogen (PWM) (Boehringer Mannneim, Frankfurt, Germany). The
.-
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cultures stimulated with the mitogens were incubated for 3 days
while the cultures stimulated with PPD were incubated for 5 days
at 370c in a humidified incubator containing 5% C02 and 95%
81r. Eighteen hours prior to harvesting 20ul (1uCi) of tritiated
'l",yq:,)dim(methyl-3H thymidine, specific activity at 24Ci/mM01e
,"Radio~~if:lmicalCentre, Amersham, England) were added to each
well. Cells were then harvested onto glass fibre filters
(Whatman Ltd., Maidstone, UK) and placed in individual plastic
scintillation vials (Packard Instruments, Illinois, USA).
Filters were dried overnight and 5ml of Instafluor (Chemiab,
South Africa) was added to each vial. Radioactivity was measured
in an LKB Rackbeta liquid scintillation spectrometer (Stockholm,
Sweden). Counts were expressed as mean counts per minute
(c.p.ro.) of triplicate cultures.
4.15. EFfECT OF THE 2SkDa MYCOBACTERIAL
FR~CTION ON THE INDUCTION OF MHC
CLASS II ANTIGEN (HLA-DR) EXPRESSION
BY CULTURED MACROPHAGES
4.15.1. Introduction
It is well documented that for macrophages to activate antigen
specific T lymphocytes, they must present processed antigen
particles in conjunction with MHC Class II (HLA-OR) Mole¢u1es
(Schroer & Rosenthal, 1geO; Shimonkevitz, 1983: Shevach &
R.osentha', 1973). The effect of the 25kDa mycobacterial
fract40n O~ the expression of HLA-DR by stimulated macrophages
was assessed in conjunction with the previous experiments.
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4.15.2. Assessment of DR Expression
4.15.2.1. Induction of DR Expression
Mononuclear cells separated by centrifugation on a hypaque-
ficoll density gradients were washed in saline, resuspended to a
concentration of 3 x 106/ml in RPM! 1640 ccntaining 10%
autologous serum and added to euch well of a 96-well f1at-
bottomed microtitra plate (200ul/well) (Ster;l;n Ltd, Middlesex,
England). The cells were allowed to adhere for SO minutes after
which the non-adherent cells were removed by washing three times
\'I'ithwarm saline. The adherent cells (macrophages) were then
grown in RPM! 1840 containing 10% autologous serum for 3-6
weeks. Purity of cells WaS assessed with the UKM1 nor.octonat
antibody (Section 4.2.1.). DR expression wa;; induced by
incubation of the ce'ls with F,co7i lijJopolysaccharide (LPS)
(E,co71 0127:B8 - Difco Labs, Detro;:., USA) at a
concentration of ZOug/ml, yeast partie'les at a concentration of
1 x 106/ml or IFN-gamma at a Loncentration of 200U/ml. The
cells were then incubated for a further G nays at 37°C. Cells
were fixed by the addition of 100ul of 0.5% paraformaldehyde to
eacn well and plates were incubated for 30 minutes at room
temperature. Plates were washed three times with phosPhate
buffer'ed saline (PBS) (Appendix 1). DR expression was then
assessed using a modified cellular ELISA.
4.15.2.2. Cellular Enzyme-Linked
!mmunosorbent Assay (ELISA) for
DR Expression
After the cells had been f';xed with paraforma'ldehyde., the wells
were treated with 0.5% BSA in a carbonatd buffer, pH 9.6
(Appendix 10) for 60 minutes. This blocking step was aimed at
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preventing non-specific binding of the monoclonal antibody.
After washing the plates three times with PBS-Tween, iOOul of
1:100 dilution of the monoclonal antibody to DR (Ortho
Diagnostic Systems Inc., Raritan, NJ, USA) were added to each
well and the plates were incubated in a humidified chamber for
120 minutes at room cempe:-ature. The plates were washed three
times with PBS-Tween followed by the addition of 100ul of a
peroxidase labelled anti-mouse IgG (Amershnm rnternat.tonat , UK).
The plates were incubated for 60 minutes at room temperature
aft~r which unbound conjugated antibody was removed by washin3
the trays three times wlth PBS-Tween. One hundred ~~:rolitres
of p=rox tdase substrate (Appendix 11) were added and the
redction stopped after 30 minutes with 50ul of 2.5M sulphuric
acid (BOH Chemicals Ltd., Poole, UK). optical densitie~ were
me'sured at 492nm in a Titretek Multiscan Me spectrophotometer
(Flow t.aboratcr+es , Biopgio, Switzerland).
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CHAPTER 5
RESULTS
, .
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5.1. SEPARATION OF STANDARDS OF KNOWN
MOLECULAR WEIGHT ON A SEPHAC~YL
S-'200 COLUMN
Figure 12 demonstrates a plot of the elution volume of known
molecular weight standards off a Sephacryl S-200 column against
the log molecular weight for ribonuclease (14kDa), chymotrypsin
(25kDa), carbonic anhydrase (3!:JkDa),bovine s-:.rumalbumin
(67kDa), alcohol dehydrogenase (150kDa); aldolase (.58kDa) and
catalase (232kDa). The experimental points lie close to a
straight lIne.
5.2. SEPARATION OF MYCOBACTERIAL ~XTRACT
ON A SEPHACRYL S-200 COLUMN
Figure 13 demonstrates that unabsorbed mycobacterial extracts can
be separated into several fractions by column chromatography.
The protein e1ution profile of extracts off suer. oephaciyl
columns is shown (mean-of 10 experiments). The major protein
peaks obtained from the column were arbitrarily identified
alphabetically from A-I. The position of molecular weight
markers used is indicated on thO'figur'e.
5.3. ASSESSME:NT OF PURITY OF CELL
SUSPENSIONS
5.3.1. Assessment of Purity of Macrophage
Cell Cultures
In order to ascert.atn whether adherent cells grown in culturu
were macrophages, the cultures were treated with the monoclonal
antibody OKM1, assessed for este~ase staining and their
phagocytic ability determined.
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5.3.1.1. Binding of OKM1 Monoclonal Antibody
By Cells in Culture
Binding of OKM1 by cells grown on tissue culture chamber slides
was assessed by counting the number of cells demonstrating
fluorescence using an indirect sandwich immunofluorescent assay.
Repeated tests consistently demonstrated a greater than 95%
fluoresence of the cell cultures, indicating binding of the OKM1
to these cells. These results were confi rmed by 3 different
observers.
5.3.1.2. Esterase Staining of Cell Cultures
Cells grown in culture on tissue culture chamber slides v/ere
assessed for esterase staining as described in Chapter 4. Section
4.2.1.2. The results indi~?~e that of 200 cells visualised
microscopically 100% were ester~se positive. Similar results
were obtained for each experiment performed. Figure 14 is a
photograph representative of one such experiment.
5.3.1.3. Phagocytic Ability OT Cultured
Monocytes
Ninety five percent of the cells on tissue culture slides showed
the ability to phagocytose yeast particles. Figura 15 shows
monocytes which have phagocytosed yeast particles. Similar
results were obtained for each eXperiment performed. Figure '15
is a representative figure of one such exper tnent ,
B~' ~se of the finding that )95% of cells were recognised by
antibodies to monocytes, were estera!S8 positive and were
actively phagocytic, the techniques emp loysd for isolating and
culturing monocyto:; were used througlJout these studies.
115.
" .".,' .. '
; . . ~ ".. . .
'.
• •• "
•.'
FIGURE 14. ~sterase staining of cell cultures.
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FIGURE 15. Phagocytic ability of cultured
monocytes
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5.3.2. Assessment of Purity of PMN Cell
Suspensions
Visual assessment and differential counting done by a Sysmex
KiDDO (Milshy Japan) cell counter indicated a >95% purity of
til€. PMN cell suspension. Sucll results were repeatedly obtained
from each experiment. Figure 16 demonstrates results obtained
for one such experiment.
5.4. THE EFFECT OF THE 2SkDa
MYCOBACTERIAL FRACTION ON THrr
PHAGOCYTIC ABILITY OF CULTURED
MONOCYTES AND PMN CELLS
To determine whether the 25kDa fraction of M.tubercu7osis
had any effect on the phagocytic capacity of phagocytes,
cu1tured monocytes and PMN cells were incubated with Bakers'
yeast in the pres(;lnceor absencC:lof 50ug/ml of the mycobacteral
extract ;'orvarying periods of time. Trble 2 (mean of 5
experiments) demonstrates tllat the 25kDa had no effect on the
Phagocytic ability of either macrophages in culture or PMN
cells, Incr·ee.sit1gthe concentration of the "lYcobacter1al
fraction to 100-200ug/m1 also was without effect (results not
shown) .
r-XGURE 16.
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TABLe; 2 L f f n c t 0 f t h n :2 5 Id.l •\ Mv c o b .).C Lfl' i ,,\1
Fraction on Phagocytic Function.
% Phagocytosis
(mean and range of 3 experiments)
PMN Cells Cultured Monocytes
Time Withoul: With Without With
(minutes) extract extract extract extract
10 28(24-32) 25(21-29) 24(22-26) 25(22-27)
20 33(30-36) 26(23-29) 28(26-30) 28(25-30)
30 78(73"'84) 78(76-80) 74(71-75) 76(72-78)
40 92(90-96) 93(91-95) 90(88-94) 89(88-90)
[.i() 96(94-97) 94(93-98) 95 (93-9'f) 96(94-98)
I
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c; "..... :.> • EFFECTS OF THE 25kDa MYCOBACTERIAL
FRACTION OF THE BACTERICIDAL
A8ILIlY OF PHAGOCYTF.S
Both cultured monocytes and PMN cells were capable of I<illing the
majority of S.aureu$ organisms within 90 minutes (Table 3).
These results are also shown graphically in Figure i7A). In the
presence of various concentratlOns of the 25kDa fraction (ug/ml),
a significant declins in the intracellular killing ability was
noted for both ce11 types (Table 3 & FigL. :I 17). The effect of
the 25kDa fraction was optimum at a concentration of 50ug/ml had
no significant additional effect on the killing ability of the
cells. The 25kOa fraction was therefore used at a concent.rat ion
of 50ug/ml.
When PMN cells and monocytes werG treated with the 25kDa
mycobacterial fraction in the presence of various concentrations
of lPN-gamma, a significant tecovery in bactericidal activity
was seen (Figure 17C). Adding lPN-gamma to the system reversed
the inhibitory action of the 25kDa fraction, with an optimum
r&versal being seen at a concentration of 100U/ml. Increasing
t.he concent rat ton fur'ther did not have any added offect.
rr:N"alpl)a i.lt a concentrat tcn of 100U/ml had no such effect
(Figure 170). Increasing the concentration of INF-alpha to
200U/ml still failed to restore the inhibitory effects of the
25kDa mvcobactsr ia1 component (results not shown).
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TABLE 3 Intracellular Killing Ability of PMN
Cells and Cultured Monocytes.
S.aureU$ mean colony count ± SD
(% killed)
Phagocytic
Cells + 25kDa
Cell Experiment Phagocytic Fraction
Type Number Medium Calls (50ug/ml)
PMN cells 1 350 10 (80) 250 (29)
2 296 4 (98) 136 (54)
:3 312 47 (85) 168 (4$)
Mean ± so 319 ± 28 40 ± 33 185 ± 5914
Monocytes 1 360 41 (81) 181 (50)
2 424 85 (80) 200 (53)
3 390 66 (83) 187 (52)
Mean ± SO 391 ± 32 66 ± 19 189 ± 10a
L..--.
a - P <.001
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Intracellular killing ability of
PMN cells and cultured monocytes in
the presence of:
(A) Medium; (8) Varying
concentrations of the 25kDa
fraction (wg/ml); (C) 25kDa
fraction + varying concentrations
of IFN~gamma (units/ml); (D) 25kDa
fractibn + 100U/ml of IFN-alpha.
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5 .6. PHAGOSOME-LYSOSOME FUSION IN THE
PRESENCE OF THE 25kDa MYCOBACTERIAL
FRACTION
Lysoscmes of both PMN cells and '~crophages in culture were
prelabelled with acridine orange and the phagocytes were
permitted to ingest live Bakers' yeast in the presence or
absence of the 25kDa mycobacterial fraction. A mean of four
experiments showed that the 25kDa fraction signifi,;antly
inhibited this process (Table 4, Figure 188). The effect of
the 25kDa fraction was optimum at 50ug/ml.
In Figure 18C the effects of varying conGentrations of
IFN-gamma all the inhibition of phagosome-lysosome fusion
mediated by the 25kDa mycobacterial fraction are shown.
Treatment with IFN-gamma partially reVersed the inhibitory
action of the 25kDa mycobacterial fraction, with optimum
effects at a concentration of 20QU/ml. !FN-gamma on its own
did not affect phagosome-lysosome fusion. The addition of
IFN-alpha at a concentration of 200U/ml also had no effect on
reversing the inhibition caused by the 25kDa fraction (Figure
18D).
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TABU' 4. Percentage of yeast containing PMN
cells and cultured monccytes
demonstrating phagosome-lysosome
fusion (as evidenced by dye uptake) in
the presence or absence of the 25kDa
mycobacterial fraction.
Cell System % % Non- % Inter-
Fused Fused mediate
PMN ce ll s + yeast 78 14 8
Monocy'c.es+ yeast 73 12 15,
PMN cells + yeast +
25kDa fraction (5flug/ml) 30 54 16
!Monocytes + yeast +
25kDa fraction (50ug/ml) 34 49 17
I
PMN ce11s + yeast +
25kDa fraction (100ug/ml) 29 52 19
Monocytes + yeast +
25f<Oa fraction (1OOug/ml ) 36 46 18
i..---
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FIGURE 18. Phagosome-lysosome fu ion in PMN
cells and cultured mo.,ocytes in th<3
presence of:
(A) Medium; (8) Varying
concentrations (ug/ml) of the 25kDa
fraction; (C) 2SkDa fraction +
varying concentrations of lFN-gamma
(units/ml); (D) 25kDa fraction +
200U!ml of lFN-alpha.
200
D
126.
Figure 19 (A & B) demonstrates )3ast particles which have
been ingested by PMN cells not incubated with the 251<Da
mYcobacterial fraction. The photograph of cells seen under UV
light (Figure 19B) shows fluorescent particles (having taken up
acr tdlne oranse) indicating successful phagosome-lysosome
fUsion,
Fi8ure 20 (A & B) demonstrates yeast particles which have been
ingested by PMN cells incubated in the presen~e of the 25kDa
fraction. Figure 208, the same section as Figure 20A observ~d
under UV light, shows dark patches where che yeast particles
occur in the previous photograph. This is an indication that
phagosome-lysosome fusion has not occurred,
5.7. LYSQSYME PRODUCTION BY PHAGOCYTES:
EFFECT OF THE ~, Da MYCOBACTERIAL
FRACTION AND IF., GAMMA
When lysosyme production w~s assessed in the presence of
several concentrations ~f the 25kDa mycobacterial fracti0n, a
dose re1ated reduct ion was observed for both PMN ce11s
A) 127.
FIGURE 19. PMN cells ingesting yeast particlerunder (A) white light and (8) U.V.
light. Fluorescent yeast particles
indicate that phagosome-lysosOffiA
fusion has occurred.
A)---- ..128.
\1
FIGURE 20. PMN cells ingesting yeast particlesin the presenCe of the 25kDa
mycobacterial fraction under (A)
white light and (8) U.V. light.
Dark patches seen in (8) in the
same position as yeast particles
seen in CA) indicate that no
phagosome-lysosomo fusion has
occurred.
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(Figure 21A) and cultured monocytes (Figure 21B). Maximal
inhibition was seen with 50ug/ml of the 25kDa myccbacter+al
fraction. Higher concentrations did not reduce lysosyme
production any further.
When lPN-gamma was included in the oultures containing 50ug/ml
of the 25kOa mycobacterial fraction, lysosyme production was
partially restored for both PMN cells (Figure 22A) and oultured
monocytas (P1sure 228). The maximal restorative ab11i1;y was
observed ('It a lPN-gamma concentrat ion of 200U!m1. XNF-gamma on
its own had no effect on the cells ab11 ity to produce Iysosyme
(results not shown),
5.8. NBT REDUCTION BY FMN ~ELLS IN THE
PRESENCE OF THE 25kDa MYCOeACTERIAL
FRACTION
When NBT reduction induced by endotoxin-activated serum (EAS)
was assessed in the presence of the 2SkDa mycobacteria'
fraction, a significant decrease in the number of cells with
positive staining was observed (Table 5), When IFN"'snmma at a
COl1centltltionof 200U!m1 was added to the cells together with
the 25kDa mycobacterial fra~t1on, NaT reduction was partially
restored (Table 5).
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TABLE 5. Effect of the 2SkDa Mycobacterial
fraction on PMN NaT Reduction.
Cell System
Number of Cells
Demonstrating NBT
Reduction II.
PMN ce11s (resting) 9 ±
PMN cells + EAS 58 ± 7
PMN cells + EAS + 25kDa fraction 26 ± tib
PMN cells + EAS + IFN-gamma 61 ± 6
PMN cells + EAS + 25kDa fraction '1
IFN-gamma 40 ;!: 30
~ Mean ± SD of 3 experiments
b P < .001
e p < .01
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5.9. EFFECT OF THE 25kDa MYCOBACTERIAL
FRACTION ON HYDROGEN PEROXIDE
PRODUCTION
The effect of the 25kDa mycobacterial fraction on the ability of
phagocytes to produce the oxygen-derived reactive soecies
H202 is shown in Figure 23. At a variety of concentrations
the 25kDa myc9bacterial fraction significantly reduced H202
production in PMN cells and monocytes (Figure 23B). lFN-gamms,
at a concentration of 200U/ml, was capable of partially
restoring the inhibition produced by the 25kDa myr.:obacterial
fraction (Figure 23C). IFN-alpha had no such restorative
ability (Figure 230).
5.10. HEXOSE MONOPHOSr"1ATE SHUNT (HMPS)
ACTIVITY IN PHA~OCYTES INCUBATED
WITH THE 25kOa MYCOBACTERIAL
FRACTION AND lFN-GAMMA AND/OR
IFN-ALPHA
Phagocytic cells incubated with Bakers' yeast part,cles in the
presence of fresh autologous serum demonstrated a burst of HMPS
activity (Table 6 - mean ± SO of 3 experiments). However, 1n
the presence of the 25kDe mycobacterial fraction a significant
decrease in HMPS activity was observed. This reduction of HMPS
activity due tu the 25kDa mycobacterial fraction was partially,
although significantly, restored by lFN-gamma at a concentration
of 200U/ml. lFN-alpha (200U/ml), however, could not restore the
HMPS activity. lFN-gamma had no effect on the HMPS activity of
resting ph~gocytes. This would indicate that lFN-gamma reVerses
the inhibitory effects of the 25kDa fraction and does not
directly stimulate HMPS activity.
134.
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H20Z production by PMN cells
and cul~ured monocytes incubated
with: (A) Medium; (8) various doses
(ug/ml) of the 25kDa mycobacterial
fraction; Cc) 50ug/ml of the 25kDa
mycobacterial fraction with
IFN-gamma (200U/ml); (D) 50ug/ml of
the 25kDa mycobacterial fraction
with lFN-alpha (200U/ml).
Mean ± SD of 3 experiments.
* p < .01 t::. p< .001
FIGURE 23.
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TABL.E 6. Effect of the 25kDa Mycobacterjal
Fraction and lPN-gamma on Phagocyte
HMPS activity.
Mean c.p.m. t SD of 3 experiments
ActivClted Cells
Incubated with: PMN Cultured
Cells Monocytes
1
Medium 24 792 ± 2 098 14 715 ± 554
IFN-gamma 24 121 ± 3 764 15 540 ± 664
25kDa Fraction a 10 074 ± 1 160 7 186 ± 1 920
25kDa Fraction +
tFN-gamma b 16 167 ± 1 652 12 721 ± 994
25kDa Fraction +
IFN-alpha 11 070 ± 1 480 6 064 ± 1 489
a P < .001
b P ( .005
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5.11. MEASUREMENT OF GLYCOLYTIC PATHWAY IN
PMN CELLS AND CULTURED MONOCYTES
The level of lactate produced by PMN cells and monocytes (Figure
24) during the glycolytic pathway was significantly reduced by
the presence of 50ug/ml of the 25kDa mycobacterial fraction in
the system. The glycolytic pathway was significantly affected
by the addition of the 25kDa mycobacterial fraction. Higher
concent r. "lnsof the 25kDa fraction had no additional effect on
glycolysis (results not shown).
5.12. ANTIGEN AND MITOGEN PRESENTATION BY
MACRO PHAGES PRE-TREATED WITH THE
25kDa MYCOBACTERIAL FRACTION
The ability of macrophagesf incubated with the 25kDa fraction,
to present both mitogens and antigens was assessed by means of
proliferation assays. Lymphocyte proliferation in response to
the mito!1ens PHA, Con A and PWM, and to varying concentrations
of the PPD antigen (1, 5 and 1oug/ml) was significantly reduced
(Table 7). Table 7 ~emonstrates that the 25kDa mycobacterial
fraction interferes with the macrophages ability to correctly
present both antigen and various mitogens to the lymphocyte.
The effect of the 25kDa fraction on macrophage presentation of
PPD is max lmal at a concentration of between 5 - 10ug/m·,.
.'
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FIGURE 24. Lactate production by PMN' cells and
monocytes in the presence of:
Serum (A); EAS (8); EAS + SOu9/ml
2SkDa mycobacterial fraction (c)
* - P <.01
** - P <.05
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TABLE 7. The Efflct of the 2SkDa MYcobacterial
Fraction on Lymphocyte Pi01iferation
to Mitogen and Antigen.
Mean c.p.m. ± SE
% Suppression in parenthesis
I Macrophages pre-
untreated treated ~ith the ,
Cell Systems Macrophages 25kDa Fraction
Control 453 ± 85 406 ± 90 (10)
PHA 52 415 ± 6 340 35 242 ± 4 495 (33)il
Con A 17 013 ± 4 228 10 719 ± 1 744 (37)11
PWM 27 479 ± 5 '422 19 530 ± 3 901 (29)&
Control 1 167 ± 194 1 098 ± 172 (6)
Ippo 1ug/ml 13 369 ± 3 920 9 687 ± 3 465 (27)b
PPO 5ug/ml 20 010 ± 2 435 15 229 ± 280 (24)J
PPO 10ug/ml 27 211 ± 4 812 22 030 ± 4 lQ4 (19)b
a - P <.001
b - P <.01
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5.13. DR EXPRESSION BY MACROPHAGES TREATED
WITH THE 25kDa MYCOBACTERIAL
FRACTION
Macrophages in culture spontanously express a low level of DR
or Class II antigen on their surface (Figure 25A). Incubating
the cells ~Iith yeast, LPS and IFN-gamma results in a marked
inoreese in DR expression (Figure 25B, C & D unhatched
res~9ctively). Addition of 50ug/ml of the 25kDa mycobacterial
fraction together with each of the DR inducing agents resulted
in a significant reduction of DR expression (Figure 25B, C & D
hatched). The spontaneous expression of DR on resting cells,
~owever was unaffected by the addition of the 25kDa fraction
(Figure 25A). Increasing the concentration of the 25kDa
mycobacterial fraction further still showed no effect (results
not shown).
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Effect of the 25kDa mycobacterial
fraction on the induction of DR
expression on; (A) Resting cells;
macrophagss stimulated with ca)
Yeast; (c) LPS; (D) IFN-garnma
1. indicates a significant increase in DR expression (P <.001)
2. indicates a significant decrease in OR expression due to the
25kOa fraction (P <.001)
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CHAPTER 6
DISCUSSION
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It has been well docu~ented that the ~ajority of mycobacteria,
including M.tubercu7osis, reside within macrophages in
tissue (Youmans, 1979; Nathan at 87., 1980). The survival
of thess organisms has been attributed to a variety of escape
mechanisms employed by M.tl.lbercu7osis organisms. Such
mechantsms may tnc lude inhibition of the production or
nellttt i Isatl0t1 of Oz metabolites (Kusuncse et: .fI7., 1976;
Jackett et a7., 1978a; Chan et a7., 1989); inhibition of
phagosomo-l y,~:osomefus ion (Armstrong & 0'Arcy Hart, 1971);
dseranlilation of lysosomes (Armstrong et a7., 1975; Densen &
Mane;£.11, 1MO: Katoh, 1981); dis rupt ion of the phasoscna 1
membrane (Mvrvik et a7., 1984) and interference with
mac r'(I~lIld~t! act ivat ion (Pabst et 8/. I 1988).
PreviOl." worl'.from this laboratory has demonstrated that sonic
extr"lcts from M.tubercu7osis could be separated into several
f'racttons by column chromatography with protein peaks I"anging in
molecular weight from >200kDa to as little as 14kDa. Of these a
prcte tn peal< of Mr 25kDa appeared to be import.ant in inhibiting
the intracellular killing ability of phagocytic cells (Wadee
et el ., 1987), while other fractions were recognised by a
specific T cell clone (Wedee at a7., 1989). In an attempt
to confirm the finding that the 25kOa fraction could inhibit
intracel1ulal" killing of M.tubercu7oGis and to furthel"
define the role played hy the 25kDa fraction, the present study
undertook to separate H.tuberculosis extracts using standard
column chromatography technology.
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For standardisation, proteins of known molecular weights ''1ere
separated through the column (Figure 12) and served as reference
markers. The protein elution profile of M.tubercu7osis
extracts off the Sephacryl $.200 columns is shown in Figure 13.
The major protein peaks obtained were arbitrarily defined A-I.
The protein elution profile obtained ~n the present study
concurred with that obtained 1n the previous study (Wadee at
a7. 1987) with Fraction H being identified as the 25kDa
fraction. Preliminary studies with this fraction indicated that
the active components present vlere carbohydrates and 1ipids.
These findings are not presented here as they have been
documentated previously (Wadee at a7., 1987) and it is not
within the scope of this diSSertation to examine the chemical
nature of the 26kDa fraction; but rather to examt ne its effects
on phagocyte function.
For these studies phagocytic ce ll» comprising both PMN cat ls and
macrophasss were employed. Initial experiments ~Iere undertaken
to confirm the purity of each of the two phagoc}te popu1ations.
The results presented in Figures ~4 and 15, and in experiments
which documented the percentage of OKM1 positive cells, clearly
demonstrate the macrophage-like properties of the peripheral
blood monocytas maintained in cultllrn. Thl. 1"311s are identified
by the monoclonal ant1bud~1 OKM1; are e~terase positive (Figura
14) and are act iva 1y phasocyt, Ic (Fisure 16).
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The purity of tha population of PMN cells used was asse~sed by
counting the cells in Turk's white cell counting fluid and by a
differential count on a Sysmex K1000 ce11 counter (Figure 16)
and were shown to be over 96% pure. Having obtained a purified
population of macrophages and PMN cells, the present study
undertook to examine the effect. of the 25kDa fract.ion on various
aspects of intracellular degradation of micro-organisms mediated
by phagocytic cells
Initial studies d~monstrated that the ingestion of yeast
particles by phagocytes was unaffected by the presence of the
26kDa fraction (Table 2). These results confirm previous
reports indicating that M.tubercu?osis does not affect the
phagocytic &bility of PMN cells and macrophages. J.fl this regard
other workers have demonstrated that macrophages infected with
mYcobacteria were capable of ingesting adequate numbets of
killed, attenuated or viable organisms (Armstrong & D'Arcy Hart,
1971), Furthermore, there is little evidence to suggest that
mycobacter ta may possess anti-phagocytic properties on their
surface (Myrvik et 87., 1984).
Yeast cells have been shown to enter phagocytic cells by
attachment to specific receptors (MFRj I3-D-glucan and C3
receptors) (Riches at a7., 1988). Since the results of the
present study clearly demonstrate the inability of the 25kDa
fraction to inhibit phagocytosis, it would therefore seem likely
that this molecule does not inhibit binding of yeast particles
to ralevant receptor's. In addition, it has been suggested that
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the C3 recaptor, among others, is also utilised by
N.tuberculosis to enter into the cells (Schlesinger et
a7., 1990). Even though this pathway of entry into macrophages
is common to mycobacteria and yeast the evidence obtained in this
study excluded the possibility of a competitive entry between the
t\~9.organisms. More importantly since two other mechanisms of
entry are employed by yeast particles and the fact that
mycobacteria do not appear to utilise the MFR and ~-D-glucan
receptors, the credibility of non-interference with phagocytosis
is confirmed. Other workers have suggested an interference of
phagocytosis by mycobacteria other than N.tubercu7osis. Cree
& Beck (1986) demonstrated that PMN cells and macrophages that
had prav tous ly phagocytosed N, tepree ingested fewer zymosan
particles on subsequent challenge. rhesa authors suggest that
the ab; 1ity of phasocvtes exposed to N. l.eprae to respond to a
second phagocytic stimulus might be impaired by ch,'ngas in the
nunbsra of binding sites on the cell surface. Thei r
ihvestigations, however, also showed that N. tubercu 70S is did
nc';' sIgl1iflcantly affect the phagocytic ability of the PMN cells
an' monocytes. Collectively such findings suggest tJ'>'\tevasion
of the bactericidal a~tivity of phagocytes by M.tubercu7osis
is independent of phagocytosis,
To examine the effects of the mycobacteria1 component on the
intracellular ki11ing ability of phagocytes, initial experiments
were previously undertaken whereby crude unf'racttcnated
mycobacteria1 extracts were used together with phagocytes. Such
experiments demonstrated thot crude mycobacterial extracts were
146.
capable of inhibiting the intracellular killing ability of
both PMN cells and cultured macrophages. In addition, these
initial experiments demonstrated that of all the arbitral11y
defined mycobacterial fractions obtained following column
separation, only the 25kDa fraction was capable of inhibiting
the intracellular killing of S.aureus organisms (Wadee et
st., 1987).
The present study WaS therefore specifically aimed at assess,lg
the mechan1sm(s) by which the 25kDa mycobacterial fraction
interfer'red with phagocyte defence mechanisms. The results shown
in Figure 178 and Table 3 indicate that the 25kDa fraction was
capable of significantly (P (.001) inhibiting the intracellular
killing of S.8ureus by both PMN ce1ls and cultured
macrophages. Inhibition of the intracellular killing ability of
phagocytes was maximal at a fina1 concentration of 50ug/ml of the
mycobacterial fraction (Figure 17B). The use of higher
concentrations of the 25kDa fraction did not further enhance the
1~hib'tion of intracellular killing ability of phagocytes (Figure
17B). In order to exclude the possibility that inhibition of
intracellular killing was due to a cytotoxic effect of the 25kDa
fraction, cell viability was assessed at the termination of the
experiment and was found to be greater than 95%.
It has been well documented that IFN~gamma is important in
activating macrophage and PMN ce11 antimicrobial activity
(Wall<er & Lowrie, 1981; Crowie & May, 1981; Nathl::lnet 87.,
1983; Morrison at a7., 1989; Van Furth, 1990). Since other
studies have also shown that IFN-gammd can reverse the
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inhibltion of intracellular degradation by phagocytes caused by
variO~$ micro-organisms (Byrne at a7., 1986; Morrison at
fi7., 1989), it was of interest to examine I'lhetherrIFN-gamma
could affect the inhibition of intracellular degradation caused
by UK! mycobacterial extract. IFN-gamma, but not lFN-alpha, was
shown to be able to partially restore the inhibition caused by
tf18 .?5kDa fraction (Figure 17C and D respectively).
Although several studies have demonstratod that the intracellular
killing of many organisms shuch as M.fortuitum (Geertsrna at
il7., 1990), s.ebortue (Canning & Roth, 1989) and
c.elbtcane tPorussia at et ., 198"f) 'Issignificantly
'jncraased by th' presence of I FN-gamma , other groups have shown
some, Dr no, affect by lPN-gamma (Rook at a7., 1986(b); Toba
et 87., 1989; Shiratsuchi et a7., 1990). A group from
Case Western Resarve University showed that IFN-gamma had no
effect on the tntracal lular multiplication of M.avium (reba
at a7., 1989) but in later studies the sarna group showed a
v{.wiaL,'le effect, depending on the strain of M. avium used in
the experiments (Shirat$uchi at s7., 19VU) It also appears
that differences between sources of macrophages affects t e
outcome of whether lFN-gamma activates the cell or not
(Shiratsuchi et al., 1990). To this end experiments have
demonstrated that IFN-gafnma caused marked inhibition of the
growth of M,tuberculos ie organisms in murine peritoneal
macrophsses (Rook at al., 1986(a» and bune marrow-derived
macrophases in culture (Flesch & Kaufmann, 1987) I whereas only
\'IElal, inh ibit ;on of growth of M. tuaercu 70S is was seen 'In human
macrophages (~o0k et a7., 1986a).
,"
148.
This in part reflects the controversy of the exact role of
IFN-gamma in activating macrophage mycobactericidal activity.
Diff~rences between strains of mycobacteria appears to be a
major component in determining the role of tFN-gamma. Such a
conclusion is exemplified by the work of Flesch & Kaufmann
(1989), who demonstrated a differential susceptibility to
IFN-gamma activated macrophages among different strains of
M.tubercu7osis. The resu'lts of this study clearly indicate
that phasocytes act ivated with I FN-gamma have an er,;'l'lhcad
killing ability for M.tubercu7osis. It is realistic to
assume that these studies are relevant to an in vivo
situation since M.tubarcu7()sis organisms were obtained from
the cultures of c11nica1 isolates.
The uechan lsms involved in the intracellular killing and
degradation of foreign organisms by phagocytes inc1ude the
f'us ion of lvsosomee to the phagosome containing the ingest,ed
organism; the release of lysosomal enzymes into the phagosome
"rid the activation of the oxidative respiratory burst with tM
subsequent production of reactive oxygen metabo1ites such as
02- and H20Z (Lowr ts , 1983). In order to re lease
hydrolytic enzymes from the lysosomes into the phogosomes
containing the invading organisms, fusion of the two organelles
mList occur. Table 4 and Figure 18B demonstrate that in the
presence of the 25kOa f'ractf cn , fus icn of phagosomes containing
ingested yeast particles to the lvscscmes is 'Inhibited. This
effect was optima1 at a coneent.ret ton of 50us/ml (F1gur'e 18).
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The photograph in Figure 20B shows a non-fuorescent yeast
particle within a phogosome, indicating an inhibition of
phagosome-lysosome fusion.
Although the mechanism(s) by which phagosome-lysosome fUsion is
inhibited has not been clearly identified, the possibility exists
that this process may involve a dysfunction of the phagosome or
lysosomal membrane or both (Goren at a7., 1976). The present
study, and several others, have shown an inhibition of phagosome-
lysosome fusion by mycobacterial organisms. Armstrong & D'Arcy
Hart (1971) showed an inhibition of phagosome-lYsosome fUsion by
intact virulent H.tubercu7osis organisms; Gordon at a7.
(1980) recognised that the addition of ammonia can inhibit
phagosome- lysosome fusion and that the content of ammonia in
culture filtrat~s of H.tubercu7osis organisms is sufficient
to account for this effect. Other studies have indicated that
polyanionic sUbstances such as suramin (D'Arcy Hart & Young,
1975) and poly-d-glutamic acid (Draper at a7., 1979) may
result in an inhibition of phagosome-lysosome fusion.
On the basis of these studies G~ren at 87. (1976) examined
the effects of a po'lvantontc subst.a.ze from H. tuberouloete
on phagosome-lysosome fusion and demonstrated similar effects to
those seen with suramin and poly-d-glutam1c acid. HOllever later
work done by Goren at 87. (19878 & b) questions the va1idity
of these atudf es , They suggest that acridine oranse is not a
good marker to lise as an indicator of phagosome-lysosome fusion
because it is capable of tr?versing biological membranes and
because it is trapped by polyanion1c substances. These
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polyanionic substances, they suggest, conce~~rate in lysosomes
as a 'g~latinous sluggishly moving hydrocolloid that ionically
traps trJe cat f ')icacridine orange," The e,bllity of the
acridine orange to traverse that membranes does not appear to be
a se~ious consideration in the present studies since the
phagOCytOSiS of viable yeast resulted in the prompt delivery of
the marker to the yeast containing phagosomes. Furthermore, no
fluorescence of the cytoplasm of the cell was observed (Figure
20). In addition, Goren et 87. (1987a & b) have suggested
that the ar tifactual ionic;~ntrapment may only apply when
polyanionic substance
used in studies of phage, ",
orange. Therefore subste .•
~. ,ctertal s~lphat1des, are
~icn Y~'n9 acridin~
. myccbacter t a 1
fraction which are not anioni~ ·,1
fusion by mechanisms other than a simplb
agoscme-lysosome
,~rapment of the dye.
FUrthermore Lowrie & Andrew (1988) expressed doubt about the
theory that the phagosome-lysosome fusion is simply an artifact
of the test system. They suqqest that the artifacts introduced
by the entrapment theory brough forward by Goren et: (17.
(1987 a & b) ccmtributes c"iY to an overestimation of the
inhibition, bl'tdoes not threaten the reality of the phenomenon
that mycobacteria do inhibit phagosome-lysosome fusion. This
lends credibility to the results of the present study indicating
the phagosome-lysosome fusion is inhibited by the 25kDa
mycobacterial fraction a'1dthat this may be 'lnG of the
mechanisms whereby mycobacteria would elude intracellular
degradation by phagncytes.
151.
In order to assess the effects of lFN-gamma on the fusion
procoss and the inhibition thereof by the 25kDa mycobacterial
f,'action these studies ware extended to tnc luds experiments in
which phagosome-1YbosC'lmt"fusion in cu1tures were examined in the
presence of either IFN-gamma or IFN-alpha. The results (Figure
18C & D) clearly indicate that lPN-'gamma(Figure 180), but not
IFN-alpha (Figure 18d), partially restores the inhibition of
phqgos,ome~1vsosone fus ion caused by the myeobacte ri a1 conconcnt .
Restoration was never complote even when higher concen!:ratioM
of lPN-gamma wer~ used. When IFN"gamma was used in control
cu ltu res the pl1agosome-lysosome fusion process was not improved
to any sit:')nif'icnntdegree. The ability of IFN-gamma to reverse
inhibition of phagosome-1YBOsome fusion adds further proof that
the entr£H)ment theory of Goren et ,~7, (iDS'fa & e) does not
apply to this svstem since the fl'action is still present, but
the dye is better able to the phagosome.
Tho results of the present study provide further evidence to
'Indicato that tl)() deflJct in bactericidal abi11ty Gould, in P{wt,
l'f) ,\sct'1bed to an inhibition of phasosome-iYSl)son1o fusion since
!rN~gL\mmal'eV~"B(H~hoth the ir",r'oce11ular ki 11in9 ability of
phU9DCytes and the inhibition of phB9QSOme-1ysosome fusion.
An effective antimicrobial mecl1anism used by pl1a.goCY'tosto
destrov invading orsantsns is mediated by the rutease of
lys()symo whiml is present in (I 111conc(antrat'Lns in specific
granulos in the cell cytoplasm (Bordon at a1" 1974).
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Furthermore the release of lysosyme from these granules has been
shown to be raised upon phatl("lcyteact ivat ton (Kowanko &
Ferl·ante, 1981; Lowrie & Andrew, 1988). Although l yscsyme has
been demonstrated to be oapable of digesting the basal layers of
the M.tuoerculosie cell walls in vitro (Takeya, at
a7" 1963) it is not effective in eliminating invading
mycobacterial organisms. The present study therefore undertook
to examine whether the 25kOa fraction had any effect on the
release of lysosyma by the pha'ocytes in addition to its effects
on phagosome-1ysosome fusion. Such studies indicata that the
25kDa mycobacterial fraction si9nificantly (P <.001) reduced
lyr,o.:'''/iilere lease from activated pha9or.ytes (Figure 21). The
effect was dose depe~dent and could be observed 5 minutes after
ce ll act ivation, The observation that this fraction depressed
lysosyme 1evels in activated 1eukocyte supernatants is in
"(!Iapingwith the findings of Ridley at 87. (1985) who showed
that lysosyme synthesis ceased in macrophag8s wh1ch had ingested
N, 7eprae. The results of the presGnt study and those
t'uf)Qrto,jby others (R1dley, 1985: I..owrie & Andrew, 1988) suggest
tllO 1ike1ihood that mycobacter t a1 organ1 sms, once ingestad and
degt'ad(~dintracel1ulary, cou1d release a fraction similar to
that described herein. This component could then either inhibit
the further release of lYBosyma; neutraliso any stored active
lvsosvna or could in the long term inhibit the de novo
synthesis of lysosyme by the phagocyte. Even though such
concepts need to be documontod, the fir,ding that t~H1amount of
lysoBymo present in the culture supernatant was reduced BS Qarly
us B m1nutes suggests that tho fraction either neutra1ises
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lysosyme or inhibits its release. In support of such a conoept
is the evidence provided by Lowrie & Andrew (,h)88)who
demonstrated a similar inhibition of lysosomal enzymes by
mycobacterial cell wall components.
Studies examining the inhibition of lysoyme release by the
mycobactarial component also undertook to examine the role
played by IFN-gamma in reversing such effects. The results
(Figure 22) clearly demonstrate the IFN-gamma sigl"ificantly
(1' <.001) reverses the inhibition G::.usedby the 25kDa
mycobacterial fraction. The effect was dose dependent and
maxfmal at a concentrat ton of 200U!ml. When higher
concentrations of IFN-gamma were used no further restcrantcn of
1ysosyma product 'Ionwas observed.
Although lFN-gamma has been shown to incr9ase lysosyme release
from both neutrophi1s (Kowanl<o & Ferrante, 19a7) and mononuclear
phagocytes (Lewis at 81., 1990), these effects could be shown
only after I hour or a 6 hour incubation period respectively.
The experimental conditions in the current investigation utilised
shorter tncubat ton periods of 30 minutes. It is therefora
unlikely tho lFN-gamma could affect the early re1ease of lysosyme
and its effects in these experiMents are thareforo due to a
reversai of the inhibitory effects of the 25kOa mycobacterial
fraction and not a direct stimulatory effect Oi'\ the lysosyme
release by the cells. Furthermore, in the present study,
lFN~gamma did net have any affect on resting phagocytes
suggesting that this lymphckine may act as a priMer of phagocyte
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lysosyme release rather than a direct activator of macro~hage
lysosyme production, Regardless of the mechanism of phagocyte
activation, the results presented herein clearly point to
IFN-gamma as a potentiator of intracellular killing mechanisms
especially in the potential role it may plat in counteracting
mycobacterial escape mechanisms.
The oxidative intracellular kil1il'~ apparatus of phagocytas also
plafs an important role in the antimicrobial activity of these
cells. This i!:l substantiated by the fact that patients with
chronic granulomatous disease, who have a deficiency of one of
the enzymes involved in the oxidative respiratory burst of the
phagocytes are incapable of killing a number of bacteria1
organisms (Baboir, 1978b), Many other studies have shown that
the ox tdat tve metabolites are important for the intracellular
killing ability of phagocytes (McRipley & Sharra, 19$7; Klebanoff
& Hamon 1975; Haidaris & Bonventre, lq82; Nathan et 87.
1983). Since mycobacteria survive intracel1ularly, it was
poss tb le tMt the rnicro-or'ganisms had an effect on ttl9 oxtdat tve
process of the phagocytes. The results of the present study
indicates that the 25kDai mycobacterial fraction in:,ibits H20.:
production by both PMN cells and cultured monocytes (Figure 23B)
(P <.001) and affects the NaT reduction by PMN cells (an assay
which measures superox1de production) (Table 5) (P <.001). This
inhibition is dose dependant and maximal at a concentrat1on of
50ug/ml of the 25kDa mycobacteria' fraction. This is not due to
a direct I.ytotoxic €ffact on the leul<ocyte since cell viability
after incubation with tho 25kDa mycobaoterial fraction for 2
hours was consistantly greater than 95%.
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M!ny studies have provided indirect evidence that Hz02 may be
an important mycobactericidal factor. Mitchison at 87.
(1963) showed that there was a correlation between the
suscept tb+l tty to H202 and vi rulence of M.tuberculos is
organisms. Jackett at ~7. (1978a), in addition, showed that
H202 produced in macrophages is tUberculocidal and that this
effect was enhanced by the 101'1pH within the cells. However,
although virulent strains of N.tuberculosis were shown to be
resistant to H20! (and therefore possibly able to calise
disease) an attenuated avirulent laboratory strain was also shown
to be resistant to H20!. The ability of M.tubercu7osis
to resist desbruct ton can therefore "ot be attributed solely to
its resistance to H202. It is possible that the conclusions
drawn by these authors provide credence to the present study
Which demonstrates an inhibition of H202 and 02- production
by the 25kDa mycobacterial fraction, thereby pt'otecting virulent
organisms fro~ destr'Q.ion.
In their studies Jackett a1. (1913) also indicate that
they cou 1d not demonst rate «n effe\~tive 02- dependent ki111ns
mechanism from N. tuberoulost«; La'ter studies by pi:lb$ltet
a7. (1988) indicate that a sulphide from M.tuberculosis
was capable of inhibiting the production of 02~ by macrophages
stimulated with PMA. May & Spagnuolo (1987) a1so demonstrated
that mycobacteria) culture filtrate, PPO and cell wall
arabinogalactan significantly failed to stimulate 02'-
production. 10£lether with the present findings, these studies
suggest that once phagocytes have degrLlded mycobacteri a,
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inhibitory molecules ~uch as the one described herein and the
mycobacterial arabinogalactan, could be released to prevent
further production of 02-.
An alternative explanation for the inability of 02- to kil' or
degrade M.tubercu7osis organisms could be that the organism
inactivatas the molecule, thereby prcltecting itse1f. Chan et
«t, (1989) demonstrated that M. 7eprao contains a phenolic
glycolipid (PG1) which scavenges O~-. It has also been
suggested that superox1de dismutase (SOD), present in the
mycobacteria, inactivates the 02- which is produced (Kusunose
et a7., t976). Although the 2SkDa mycobacterial fraction
could be acting in a similar manner, the fact that it interfe,'ss
with several other systems involved in intrace11ular' killing
makes this unlikely.
Activation of phagocytes by IFN-gamma results in an enhanced
production of oxygen radicals (Pick. 1985; Cassatel1a et
87'1 1988; Bel1stab & Schaffner, 1989) and an enhanced ability
of the cell to kill invading organisms (Walker & Lowrie, 1981;
Haidaris & Bonventrs, 1982; Nathan at a7., 1983). To such
ends Walker & Lowrie (1981) demonstrated tl':atmouse per'ltoneal
macrophases actiVated with lymphokines had an tncrsssed ability
to kill n.mcrott, In addition they also demonstrated that
the cells nad an increased ability to prodUce H20? and that
this raised H202 production was responsible for the
increased killing of the organism. In the present study the
addition of IFN-gamma, together with the 25kDa mycobacter tat
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fraction resulted in a significantly increased production of
H~n2 (P ',001) and 02- (P <.01) as compared to cUltures
with the 26kDa mycobacterial fraction alone (Figure 23C and
Table 6, respectively). Such findings are not surprising since
several studies have pre. ided evidence in favour of IFN-gamma
acting as a primer of phagocyte function and in particular to
that of H202 and 02- production. These include studies 1n
which H202 production by PMN ce'I15 in response to a variety
of stimuli was enhanced in the presence of rIFN-gamma (Berton
at a7., 1986; Cassatella at a7., 1988). The present
studies also suggest that IFN-gamma acts as a primer of
intracellular killing mechanisms since this 1ymphokine had no
stimulatory effect on its own but was capab1e of partially
restoring tho functions inhibited by the 251<Da mvcobactar+al
fraction (Table 5).
Act ivat ion of an NADPH ox idase systenl resul ts in the production
of superoxide and H202 (Babior, 1i78a). Thi' ultimately
t....ansfers an elect':m from NADPH to molecular oxygen. During
this process the NADPH is oxidisad to NADP and it is the
availability of this latter co-enzyme which controls the rate of
oxtdat ton of glucose-6"'phosphate via the HMP$ (Bab tor , 1976a).
Analysis of the HMPS pathway is therefore another means at
assessing the respiratory burst of the cell. In accordance with
the results obtained for the NBT assay the HMPS was also
significantly reduced (P (.001) in the presence of the 25kDa
mycobacterial fnH;t ion at a concentration of 50ug/ml (Tab1e 6).
IFN~gamma (200U/m1) I but not !t"l~"alpha,partially reversed the
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affect of the 25kDa mycobacterial fraction. Wilson et 87.
(1986) indicated that lipids, sphinganine and sphingosine
inhibit the oxidative burst in human neutrophils. This Vias
thought to be mediated by inhibiting the act.ivation of the
NADPH oxidase system. Previous studies from this laboratory
(Wadee et a7., 1987) have suggested that this may indeed be
the case. Tn these studies, the 25kOa mycobacter tal fraction
was identified to be compr lsed of protein, carbohydrste and
lipid. Chemically modifying the fraction indicated that the
important constituents were the carbohydrate and lipid
moieties. Results not presented here indicate that these
components were crucial to the inhibitory effect of the 25kDa
mycobacterial fraction, since removal of these constf tuents
resul tad tn a revel-sal of their inhibition of HMPS sct iv+ty to
control levels. It is therefore possible that the lipid and
carbohydrate components present in the 25kDa mycobacterial
fraction may act in a similar manner to that described by Wilson
et a7. (1986) in inhibiting the ac~ivation of the NADPH
cxtdase system. This rematns a poss ibt li'W that requt res
fUrther evidence for documentation.
Previous reports have indicated tha.t glycolysis is the main
source af the eneP~y required for phagocytosis (Sbarra &
Karnovsky, 1959; Gohn & Morse, 1960; Ciine, 1966). Adenosine
triphosphate (ATP), wh'!ch is utilised to phosphorylate glucose
during glycolysis, is also the source of energy required by the
cells for phagocytosis. It is during cleavage af this molecule
that large amounts of energy are ,released (Ka.rnovsky, 1962).
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Although phagocytosis of yeast particles remains unaffected
by the 25kDa mycobacterial component it was still of interest
~o determine whether this factor had any effect on the
glycolytic activity of phagocytes since stored ATP might
provide sufficient energy to maintain phagocytosis for a short
period of time. Another reason for examining this metebolic
pathway is the fact that the glucose-6-phosphate required by
the HMPS is provided for by glycolysis (Baboir, 1978a). In
this system, glucose is phosphorylated to glucose-6-phosphate
which new enters the HMPS. The present study has demostrated
that the 25kDa mycobacterial component significantly suppressed
HMPS activity (Table 6). ~ven though this component has been
shown to interfere with the production of superoxide Mion and
the oxidation of NADPH to NADP as assessed by NBT reduetion, it
does not exclude the possibility that HMPS activity may be
inhibited due to a reduced supply of energy and glucose-6-
phosphate resulting from an inhibition of the glycolytic
pathway. The results pr'e$ented iii Figure 25 c lear ly
d~monstrate that the mycobacterial fraction significantly
affected the glycolytic pathway of activated phagooytes. rt is
possible though that the stored ATP within cells is sufficient
te provide the energy for phagocytosis. These findings also
point to the fact that the inhibitory effect of the
mycobacter-i al fraction is in the disruption of intraoe1lular·
killing systems rather than the phagooytic potentia1 of these
cells.
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The present studies have indicated that H.tuberculosis
organisms have the ability to evade intracellular degradation by
preventing or inhibiting a variety of bactericidal mechanisms.
Since intracellular degradation is neccessary for macrophages to
be able to present antigen to lymphocytes, the present study
undertook to examine the role, if any, of tile mycobacterial
fraction on the presentation of antigens by macrophages. These
studies were performed by the u~e of two experimental systems,
The first system comprised an investigation into the
proliferative response of lymphocytes to mitogens and an
antigen, in the presence of monocytes pre-treated with the 251<Oa
mycobacterial fraction. The results indicate a significant
suppression of lymphocyte blastogenesis to the mitogens PHA, Con
A and PWM and to the antigen PPO (Table 7). The results of the
present study suggest tharef'ore that in addition to inhibiting
the intracellular killing ability of phagocytes, the 25kOa
mycobacteria' fraction has the ability of interfering with
ant tsen presentation by macrophag9s as well. It is possible
that this is a dtr~ct conseQuence of poor antigen processins. as
evidenced by an inhibit'lon of the tntr'acal luar degradat1ve
mechanisms and due to a reduced prol'lferation '':!ecauseof
inhibition of the glycolytic pathway. ih-Is could add to its
effects and lend more credibility to the mycobacterial component
as an immunosuppressive asent. The present study did not.
explore these avanups any further as it was beyond the scope of
this dissertation. Nevertheless, these findings agree in part
with those presented by Ellner & Daniel (1979) and by Kleinherz
at a7. (1981) who demonstrated that a mycobacterial
component, arabinomannan, was capable of suppressing macrophage
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The present studies have indicated that M.tuberculosis
organisms have the abi1'ity to evade intrace1lular desradat tcn by
preventing or inhibiting a variety of bactericida1 mechanisms.
Since tntrace lluter degradation is necoeseary for macrcphapes to
be ab1e to present antigen to lymphocytes, the present study
undertook to examine the role, if any, of the mycobacteria1
fraction on the IJresantation of antigMs by macrophages. These
studies wera performed by the use of two experimenta1 systems.
The first system comprised un inVestigation into the
proliferative response of lympho~yt8s to mito~ens and an
antigen, in the presence of monocytes pre..treated with the 251<Oa
mycobacterial fraction. The results indicate a sigrificant
suppression of lymphocyte b1astogenesis to the mitogens PHA, Con
A MrJ PWM and to the antigM PPO (Table 7). 1'he reSll't~of the
present study suggest therefore that in addition to inhibiting
the intracellular killing ability of phBgocytes, the 26kOa
mycobacterial fraction has the ability of interferins with
antigen presentation by macrophag~s as well. It is posSible
that this is a direct consequence of poor ant.tsen proceSSing, as
evidenced by an inhibition of the intrace,1uar dogradative
mechanisms and due to a reduced prol'1feration because of
inhibition of the glycolytic pathway. This cou1d add to its
effects and lend more credibility to the mycobacterial component
as an immunosuppressive agent. The present study did not
explor~ these avenues any further as it was beyond the scope of
this dissertation. Nevertheless, these findings Bsree in part
with those presented by Ellner & Danial (1979) and by Kleinharz
at a7. (1981) who demonstratod that a mycobacterial
component, arab1nomannan, was capable of suppressing macrophage
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dependent, antigen-induced activation of human lymphocytes.
They suggest that there is an act.ivation of suppressor
macrophages which downregulate the immune response ty a negativd
feedback rnechtlnism. Whether the 2510£1 mycobacterial fraction
acts in a similar manner or whether it prevents the macrophage
from processing a"d presenting antigen has not yet been
determined. However, the resu1ts of the present study suggest
~h~~ the 25kDa mycobacterial fraction may be acting at the level
of inhibiting the processing and presentation of antigen by
macrophasee rather than a d'iract acttvat ion of suppressor
macrophages (Table 7). This is confirmed by further experiments
which indicate that there is .a reduced expression of Class tI
antigens on macrcphasee inr:'lbatedwith the myccbacter te i
component. In a second ser'iss of experiments, the expression of
the HI.A Class II ant 'I gens in response to macrophage activation
was assessed, In these studies, aJherent monocytes were
activated in the presence of the 25kDa mycobacterial fraction.
The e){pression of DR antigens was induced b;, incubat 1ns ce l s
with LPS, Bakers' yeast or IFN-gamm8. other systems containqd
these activators in the presence of the 25kDa fract'lon. Results
obtained from a mod1f1ecl cellular l:I..ISAused to determil~~ DR
expression (Figure 26) demonst,rate a marked inhibit'lon of Class
II antigen expression b>' the 25kDa fraotion. Class II
expression of resting macrophages was unaffected (Figure 26)
just as thf) express len of such antigens was not affected by the
2$kDa fracti~n if it.were add~d to prestimulated cultures
(resu1ts not shown). These findings sugges",.that mycobacteria
have the ability of interfering with the expression of t.ie Class
II molecules if prosent prior to or at the time of maoropha~e
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activation. However since the 25kDa mycobacterial fraction
does not affect ore-act tvated cells, the present studies suggest
an additional role for this mycobacterial component in
inhibiting the activation of resting macrophages. This is
important for the pathogenesis of tuberculosis. If the initial
number of infecting organisms is small, the macrophage activated
by cytokines, such as lFN-gamma, is able to present the degraded
antigen together with Class II antigens to lY,i,phocytesand so
activate the CMI response. However, if the infective dose is
high, the degraded material which is released could prevent
further activation of the othel" macrophages and so cause immune
suppression and consequently tuberculosis. Whether the
inhibition of Class II expression is mediated by an interference
in the actual synthesis of the Class II antigen or by an
abroqat.ton of tr=isport to the cell surface is at present
unclear'. This aspect of the effect of the 25kDa mycobacterial
fraction obviously requires further study.
The interaction of mycot-acteria with macrophages in relation to
the expression of OR antigens by the latter has been the subject
of investigation by several groups recent ly. An examination of
pet'ipheral b100d from tuberculous patients demonstrated that the
macrophage papulation 9xpreS"ng DR antigens in this group was
considerably decreased in comparison to normal healthy controls
ITweal'dy et si., 1')84; Ellner, 1986). This Was cart tcuj arlv
true for pat ients who had a depressed response to PPQ.
Fut'thermore, when nacrcchaaes from these patients ware grown in
culture 24 hours, their expression of Class II antigens rose to
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normal levels. Even though these authors have suggested that
the increase 'InDR expression may b')due to a maturation of
cells in culture (Tweardy at 87., 1984), it is possible that
the high concentret ton of the mycobacterial components present
in the circulation could inhibit the macrophage's ability to
synthesise or expr~ss DR on their surface and once cells are
left in culture this inhibitory effect may b6 lost, thus
allowing the cells to express DR. This is particularly relevant
to the present study which demonstrates a significant reduction
of Class II antigen expression in the presence of the 25kOe
fraction. It is possibie that the macrophages ~n the presence
of mycobacteria and in particular the 25kDa myeobacterhl1
fraction could present less antigen not on1y by inhibiting the
various tnt.raoal luar processing mechanisms but also by
inhibiting the expression of Class II antigens. Current
immunological dogma states that activation of C03+, CD4+
helper/inducer lymphocytes occurs by antigen presentation 'Inthe
presence of Class II antigens. However antigen presentation to
suppressor cells does not occur via Class II but rether by the
expression of antigen in the presence of Class I antigens. In
keeping with such thoughts, the studies of iweardy et a7.
(1984) and Ellner (1986) clearly shaw the activation of
suppressor t:e11s by macroo.rassa not express ins Class II
ant1g'ns. This lends support to the poss1b11'1ty of reduced
cellular immune responoes due to mycobacterial comf,lonentssuch
as the 25kDa fraction.
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Simi1ar reports have demonstrated that other mycobacteria also
have the ability of inhibiting HLA Class I! expression. Kaye
et a7. (1986) showed the expression of la by mouse
peritoneal macrophages was increased by IFN-gamma and that this
expression was suppressed by M.microti. Similarly Collings
et a7. (1985) and Poulter et a7. (1984) described d
reduct ion of HLA-DR express ion by ce 11s from 1es ions of pat 1ents
itlfected with n.Leoree, Collectively, these results point
to an additional mechanism adopted by mycobacteria to avade the
host's immune system. By reducing HLA-DR expression the
mycobacteria suppresses the hos'ts ability to activate a cell
mediated immune response and to irradicate the invading
organism. With regard to UI9 25kDa fraction described herein,
the resu 1ts suggest a mode 1 whereby mycobacteri a upon ingest 'Ion
and degradation release this factor which Gould in turn inhibit
activation of any other macrophages in the surrounc'ing area thus
ensuring the SUt' .va l of t'emaining mycobacteria which may
subsequent 1~' be phagocytoSed.
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CONCLUSION
This study is in accordance with previous work dona in this
laboratory (Wades et a7., 1987) and c)early demonstrates
that a 26kDa mycobacterial fraction obtained by separating
sonicated M.tubercu7osis extracts by column chromatography
inhibits the intracellular killing ability of both PMN calls and
macrophaass. To mOl e sPecifically determine the mode of action
of the mycobacterial fraction, its effects on various st(~ .
involved in thb microbicidal pr lcess of the phagocytes were
studied. Although the 25kDa mycobacterial fraction has no
effect on the ab'111ty of these cells to ptlagocytot;eforeign
material it Significantly inhibits the ability of phagosomes
(containing inSested yeast) to fuse with lysosol\lssand it also
inhibits the release of lysosyme from the 'y~osomal granules.
In addition to the inhibition of possible enzymatic degradative
processes, the 2SkDa mycobacterial fraction also significantly
inhibited the production of toxic oxygen radicals such as
1-1202 and 02 anion, probably by inhibiting one or more
'steps of the HMPS pathway. Glycolysis which provides the energy
for the I-IMPSpathway was not significantly affected, indicating
that the 25kDa mycobacterial fraction affected the oxidative
systems of the cells rather that the energy providing pathways.
Since the degradative mechanisms of the cell are so efficiently
inhibited by the mycobacterial component, it was interesting to
see whether the fraction affected the antigen presenting
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fUnction of macrophages. The 25kDa mycobacterial fraction was
shown to significantly inhibit antigen and mitogen presentation
to lymphocytes. Important components for antigen presentation
by ".acrophages is intracellular degradation of the )Iore;g"
('\'q;.nismand presentation of the resulting ahtig~nic fragments
in conjunction with DR to the lymphocytes. In addition to the
inhibition of the intracellular degradative process the 25kDa
mycobacterial fraction also inhibited the ability of activated
macrophages to express DR on its surface.
These results provide some explanation for the pathogenesis due
to inrection with mycobacterial organisms, in particu1ar
M.tuberculosis. Once ingested, the organism couid be
degraded and the breakdown products could contain a 25kDa-like
mycobacterial rract:Qn which would then prevent further
degradati~n of the ingested mycobacteria. These could then
accumulate intracellularly and result in the pathology
associated with tuberculosis.
The presant study also ascertained thnt !FN..gamma but not
IFN-alpha was able to partial'ly reverse the inhibition caused by
the 25kDa mycobacterial fraction in each or the systems which
were affected. These studies would indicate that IFN-gamma can
be an important therapeutic agent Tor the treatment of
tuberculosis since it enhances the pha.gocytes ability to kill
and degrade the invading M.tuberculoeie organisms. The
results also l:luggestthat IFN-garnma may have 01 intcal relevance
in the treatment of mYcobacterial diseases.
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APPENDIX 1
Phosphat~ B~ffered Saline (PBS) O. 15M (pH 7. 2 )
OOOml
NaCl (Univar, South Africa) 89
KCl (Urrlvar , South Africa) 0.29
Na2HP04-2H20 (BDH, Poole, England) 1.159
KH2P04 (BDH, Poole, England) 0.29
Dissolve in 9DOml distilled water.
Adjust the pH to 7.2.
Make up to 1 OOOml with distilled water.
Sterilise by autoclaving.
APPENDI'( 2
Am11.1Qn. j_ldm .. pJ).J_QLi q~.J~H:l4.9.1 0,83%
OOOm1
NH" Cl (Merck, Darmstadt, Qermany) 8.49
KHC03 (Merck, Darmstadt, Germany) 1.099
EDTA (Merck Darmstadt, Germany) 37.~tllg
Filter sterilise.
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APPENDIX .3
2 ml of 6 X 106 yeasts/ml were centrifuged at 4009 for 10
minutes.
Yeasts were resuspended ;n 2ml of fresh human serum and
incubated at 3700 for 30 minutes.
The opsonized yeasts were kept on ice until needed.
APPENDIX 4
El1t;:1.o!<9Xi0_ .AQ.t·j.'fat§)d __Q.~rutILLEA~.1
,reah human serum was incubated with 5mg/ml of
lipopolysaccharide (£.0071 0127:B8 - f.i1fcoLaboratories,
Detroit, USA) at 37°C for 45 minutes.
Aliquots of the EAS were stored at -200e until needed.
APPENDIX 5
NBT reagbnt, (Grade III - Sigma, St. Louis, MO, USA) was prepared
by dissolving NBT in PBS at a concentration of 1mg/m1.
The solution was left at 560C in order to dissolve the NBT
crystals.
The solution was then centrifuged at 8009 for 10 minutes to
remoVe any undissolved dye particles and the supernatant was
collected and stored in the dark at 4°C.
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APPENDIX 6
Haematoxylin crystals
Absolute alcohol
Potaasium alumin;umsulphate
Distilled water
Mercuric oxide
Glacial acetic acid
5g
50mi
1009
000101
2.59
40101
Dissolve potassium aluminiumsulphate cry~ta's in boiling
distilled water.
Dissolve haematoxylin in a~cohol.
Mix the two solutions and bo;l rapidly.
Remove from the heat and add mercuric oXide slowly.
Heat solution until it becomes dark purple.
Remove immediatelY and plunge flask into ice water.
Add aCetic acid to cold solution.
Filter before use.
APPENDIX 7
Phenol. Bt;ld
5mg of phenol red (Merck, Darmstadt, Germany) in 10101 of saline
was dis!>Olved by incubating at 370C fot' 30 minutes.
Solution was filtered through a 0.45 micron filter before use.
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APPENDIX 8
1 OOOml Instagel (Packatd, Illino;s, USA)
5.5m110M He 1
Acid was added slowly to the Instag~'i whi1~ stirring.
The solution was stirred until all the acid was dissolved.
APPENDIX 'i
3.75g glycine
2ml 20M hydrazine hydrate
Make up to 100ml with distilled water.
APPENDIX 10
O.05M (pH 9.6) 1 OOOml
Na2C02
NaHCOa
(BDH, Poole, England)
(BOH, Poole, England)
i.590g
2.930g
Make up to 900ml with disti11ed w&ter.
Adjust pH to 9.6
Make up to 1 OaOml with distilled water.
Dissolve 0.5g BSA (Seravac Pentex Products, 1111n01s, USA) in
100ml sodium carbonate buffer.
store ut -20c~ until needed.
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APPENDIX 11
Peroxidase Substrate for cELISA
A) Supst~ate Buffer
citric acid
NS2HP04
(BDH, Poole, England)
(BOH, Poola, England)
1.029g/100ml
1.4489/1 OOm 1
Dissolve in distilled w&ter.
Adjust to pH 5.0.
Maka up fref,h daily.
B) Substrat~
Immediately prior to use add t5ul of cold 30% H202 (BDH,
Poole, England) and onEl Q-phenylenediamine tabl"t (Zymad
tabcratc r+es Inc., cat lfcrnte , USA) per 12ml substrate buffer.
Keep the substrate solution entirely covered until used.
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